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ABSTRACT OF THE DISSERTATION 
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by 
 Brian Christopher Miller 
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Washington University in St. Louis, 2011 
Professor Herbert W. Virgin, IV, Chairperson 
 
 Macroautophagy (herein autophagy) is a process by which cells degrade long-
lived proteins and organelles.  The autophagy pathway and autophagy genes have been 
implicated in many functions in the cell such as protecting against metabolic stress, 
degrading damaged organelles, and regulating vesicular trafficking.  To study the role of 
autophagy in primary cells with important physiologic functions, we generated mice 
lacking essential autophagy genes in B lymphocytes, T lymphocytes, and osteoclasts.  
We found that the essential autophagy gene Atg5 was important for B cell development 
and for the maintenance of B-1a B cell numbers but not peripheral B-2 B cell numbers.  
In T cells, deletion of the essential autophagy genes Atg5 or Atg7 resulted in decreased 
thymocyte and peripheral T cell numbers in vivo and a decrease in cell proliferation in 
vitro.  Autophagy genes play a critical role in T cell homeostasis, but do not appear 
important for peripheral B-2 B cell homeostasis in vivo.  Whole-genome transcriptional 
profiling of Atg5-deficient and wild-type thymocytes suggested abnormalities in 
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mitochondria in the absence of Atg5.  We confirmed this observation by demonstrating 
that peripheral Atg5-deficient T cells had an increase in mitochondrial mass that 
correlated with increased Annexin-V staining in these cells.  We speculate that autophagy 
is required in T cells for the removal of damaged or aged mitochondria and that excess 
mitochondria contribute to increased cell death in autophagy-deficient T cells.  In 
contrast to lymphocytes, deletion of autophagy genes in osteoclasts did not result in 
dramatic abnormalities in cell development.  However, the biochemical pathway 
necessary for autophagy was critical for directional secretion in osteoclasts.  We found 
that the autophagosome marker LC3 localized to the resorptive microenvironment in 
osteoclasts.  Deleting Atg5 or Atg7 or overexpressing a dominant negative mutant of 
ATG4B to inhibit LC3 conjugation reduced localization of lysosomal markers at the 
resorptive surface and decreased bone resorption in vitro.  Furthermore, mice lacking 
Atg5 in osteoclasts and other myeloid-lineage cells were protected from ovarectomy-
induced bone loss, a mouse model of osteoporosis.  Together, these studies demonstrate 
that autophagy genes are important in cell development, survival, mitochondrial 
maintenance, and directional secretion in physiologically important, primary mammalian 
cells.  
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Overview 
 To maintain homeostasis, cells must both build new macromolecules and 
organelles and degrade excess or damaged ones.  Macroautophagy (herein autophagy) is 
a cellular degradative process by which cells recycle both organelles and long-lived 
proteins.  This process is critical for survival, as mice lacking one of the genes required 
for autophagy die within one day of birth1,2,3.  This introduction will give a summary of 
the process of autophagy and the functions of autophagy genes, with an emphasis on their 
roles in cell survival and vesicle trafficking and secretion.  The work presented in this 
thesis will describe the functions of autophagy genes in lymphocytes and osteoclasts, so 
the development, survival, and function of these cells will be briefly discussed.   
The Autophagy Pathway 
 While the molecular machinery of autophagy was first characterized in yeast, 
gene homologues have been discovered in higher eukaryotes, suggesting that the process 
is evolutionarily conserved.  The autophagy pathway can be divided into four stages: 
vesicle nucleation to form an isolation membrane, expansion and closure of the isolation 
membrane around cytoplasm to form a double-membrane bound autophagosome, fusion 
of the autophagosome with the endo-lysosomal pathway, and breakdown of vesicle 
contents in the lysosome (Fig. 1-1).  Autophagy can be induced by a variety of cellular 
stresses, although many mammalian cell types appear to have some level of constitutive 
autophagy4,2.  These stressors include starvation4, growth factor deprivation5, ER stress6,7, 
microbial infection8,9,10,11,12, hypoxia13,14, and accumulation of reactive oxygen species15. 
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 While the conditions that produce these stress signals are diverse, many of their 
signaling pathways converge in the inactivation of the serine/threonine kinase mTor, a 
master regulator in the initiation of the autophagy cascade.  Inhibition of mTor activity 
results in activation of a class III phosphatidylinositol 3-kinase, Vps34, in complex with 
Beclin-1 and other molecules (reviewed in 16).  Activation of this class III PI3K is 
necessary for nucleation of the isolation membrane17 (reviewed in 18). 
 Formation of the autophagosome requires the recruitment of two ubiquitin-like 
pathways necessary for isolation membrane elongation and closure19.  The E1-like 
enzyme required for both conjugation systems is ATG720,21,1.  The first system conjugates 
the ubiquitin-like molecule ATG12 to a lysine in ATG5 via the action of the E2-like 
enzyme ATG1020,22,23,24.  The majority of ATG5 in mammalian cells is found conjugated 
to ATG1224.  ATG5-ATG12 binds to ATG16L1, which is thought to target the complex 
to the forming autophagosome25.  The ATG5-ATG12 conjugate has E3 ubiquitin ligase-
like activity for the second ubiquitin-like system, the ATG8 conjugation system26.  There 
are many species-specific homologues of ATG8 in mammalian cells, including LC3, 
GATE16, GABARAP, and ATG8L27,28,29, although LC3 is the best characterized of these 
molecules in the context of autophagy. 
The ubiquitin-like molecule LC3 is first cleaved by ATG4B, a mammalian 
homologue of yeast ATG430,31, exposing a C-terminal glycine residue and forming    
LC3-I30.  LC3 is then activated by ATG7, transferred to the E2-like enzyme ATG3, and 
finally conjugated onto the lipid phosphatidylethanolamine (PE) via an isopeptide bond 
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with the exposed glycine residue32,30.  Conjugated LC3 (LC3-II) localizes to the isolation 
membrane30,31 where its membrane-fusion activity is thought to mediate proper 
membrane expansion and/or closure33,3,34.  ATG4B also functions to deconjugate LC3 
from PE after formation of the autophagosome35.  Interestingly, a recent study has 
suggested that macroautophagy may exist in mammalian cells by a mechanism that does 
not require the ATG12/LC3 conjugation cascades36.  Although the physiologic 
significance of this alternative pathway is unclear, this finding highlights the complexity 
of mammalian autophagy. 
 Much less is known about the molecular mechanisms required for the fusion of 
the autophagosome with endo-lysosomal vesicles in mammalian cells.  This step likely 
involves machinery important for the endo-lysosomal trafficking pathway such as the 
Rab small GTPase family.  Indeed, Rab7, which is involved in late endosomal transport, 
phagosome maturation, and lysosome homeostasis37,38,39, has been shown to be important 
in the fusion of autophagosomes with late endosomes/lysosomes40,41,42.  After fusion, 
lysosomal enzymes degrade the contents of the inner membrane43 which are subsequently 
exported back into the cytosol to be recycled as substrates of synthetic pathways.  
Measuring Autophagy 
 The development of reliable and quantifiable assays to measure autophagy over 
the past two decades has allowed significant advancement in this field.  Autophagy was 
first discovered by electron microscopy, and this technique is still widely used to quantify 
autophagosomes44,45,46.  The lipidation of LC3 during autophagosome formation allows 
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unconjugated (LC3-I) and conjugated (LC3-II) forms to be distinguished by their 
electrophoretic mobility30.  Because LC3 is degraded when the autophagosome fuses with 
the lysosome, inhibiting lysosome degradation is important for measuring the 
accumulation of LC3-II as a measure of autophagic activity over time (reviewed in 44).  A 
GFP-LC3 fusion protein has also been generated to allow the localization and 
quantification of autophagosomes within cells30 (reviewed in 44).  It is important to note 
that LC3 can be conjugated in the absence of autophagosome formation (reviewed in 44) 
and form punctuate structures independent of autophagy47.  Finally, levels of the protein 
p62, which binds LC3 and is degraded by autophagy48, are used as a indicator of 
autophagic activity (reviewed in 44). 
Functions of Autophagy Genes 
 In addition to its role in recycling, autophagy has been implicated in many cellular 
functions based largely on studies using gene knockdown and gene deletion approaches.  
However, autophagy genes may have other functions in the cell.  For example, the 
requirement for Atg5 in autophagy is clear49,24, but Atg5 can also induce cell death and 
inhibit cytokine production independent of its role in the LC3 conjugation 
pathway50,51,52,53.  Given this caveat, there is a growing literature suggesting that 
autophagy or autophagy genes function in many different contexts in the cell (reviewed 
in 54).   
 The function of autophagy genes shows remarkable cell-type specificity.  For 
example, numerous secretory cells have co-opted autophagy genes for their specialized 
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function55,56,57,58,59, whereas antigen presenting cells use this pathway to process 
cytoplasmic antigens for presentation60,61.  Other functions of autophagy and autophagy 
genes seem to be conserved in many different cell types – for example, the ability of 
autophagy to maintain cell viability during starvation and stress5,62,63 or degrade 
intracellular pathogens12,64,65. Because of the cell-specific and multifunctional roles of 
autophagy genes, it is important to study their function in physiologically relevant cell 
types. 
Autophagy genes in cell survival 
 One of the first discovered functions of autophagy is to maintain cell viability 
during cell stress5,66,67.  Autophagy genes have been shown to be important for cell 
survival after removal of growth hormones, conceivably by allowing cells to acquire 
nutrients from the degradation of cellular constituents5.  In conditions of hypoxia, 
increased reactive oxygen species (ROS) production, or mitochondrial damage, 
autophagy can be targeted to degrade mitochondria to protect cells from the toxic 
byproducts of mitochondrial respiration13,14,15,68.  Deletion of autophagy genes in yeast or 
murine liver, β-islet cells, embryonic fibroblasts, cell lines, or macrophages results in the 
accumulation of mitochondria69,57,1,70,71,72. 
 ROS are one of the major destructive byproducts of mitochondria.  ROS can 
induce DNA damage and oxidize proteins and lipids necessary for cellular function and 
survival73,74,75.  Many different cell types have been shown to accumulate ROS when 
autophagy genes are knocked down or deleted, including yeast69, mouse embryonic 
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fibroblasts15,70, transformed fibroblasts72, and macrophages70,76.  In addition to decreasing 
ROS levels, autophagy may also mitigate the negative effects of ROS by degrading 
oxidized protein aggregates and damaged organelles77,78,79,80.  As evidence of the in vivo 
importance of this function of autophagy, inhibiting autophagy genes in Drosophila or 
Arabidopsis increases the sensitivity of the flies and plants to oxidative stress-induced 
death79,80.  As ROS have been shown to induce autophagy in various cell types15,81,82, this 
suggests a negative feedback loop whereby increased ROS activate autophagy, which 
functions to decrease ROS levels and allay the effects of ROS damage.   
 Paradoxically, a few studies suggest that autophagy can increase ROS, resulting 
in cell death83,84.  Many groups have reported that inhibition of autophagy results in 
decreased cell death85,86, even in the same cell types where it has been shown to have pro-
survival functions66.  Autophagy can function to induce or accelerate cell death (i.e. 
autophagy causes an increase of ROS that are toxic to the cell83), but it may also be a 
distinct mechanism by which cells can die (reviewed in 87).  The function of autophagy as 
cell death mechanism is unclear and will not be further discussed in this thesis (reviewed 
in 87).  Still, it is clear that autophagy can function to both protect cells and induce cell 
death.  One hypothesis to explain this paradox is that autophagy normally has a 
cytoprotective role, but can result in cell death when overutilized (reviewed in 88). 
Autophagy genes in vesicle trafficking and secretion 
 Many of the proteins involved in the induction of the autophagy pathway also 
have functions in vesicular trafficking.  The Vps34 complex, for example, can pair with 
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different subunits to induce autophagy or function in endosomal vacuolar sorting89,90 
(reviewed in 91).  There is now a growing literature suggesting that autophagy genes 
downstream of the Vps34 complex can have a role in vesicular trafficking independent of 
autophagosome formation.  Atg5 is important for the fusion of phagosomes with 
lysosomes in macrophages92.  Beclin-1 and LC3 were found to localize on the 
phagosome, but no double-membrane bound structures associated with the phagosome 
were observed.  Atg5 is also important for clearance of Toxoplasma from infected 
macrophages65.  Atg5-deficient macrophages failed to localize a key immunity-related 
GTPase, Irga693, to the vacuole containing the parasite (parasitophorous vacuole) and 
failed to recruit LAMP1 positive lysosomes to this structure.  No double-membrane 
bound structures were observed associated with the parasitophorous vacuole.  
Interestingly, both of these papers report a defect in the fusion of lysosomes with 
intracellular vesicles, raising the possibility that a common mechanism is involved in 
both processes. 
 A novel role of autophagy genes in cell secretion has also been recently 
suggested.  Paneth cell secretion of lysozyme is deficient in mice that have deleted or 
reduced levels of ATG5, ATG7, or ATG16L1 in the gut epithelium55,56.  Deletion of Atg7 
in pancreatic β-cells disrupts insulin secretion57,58.  Finally, mice heterozygous for 
Beclin-1 have a deficiency in melanosome production by melanocytes, resulting in 
alterations in coat color59.  These studies provide compelling evidence suggesting a role 
for autophagy genes in granule secretion, and it will be important to determine if this 
function is generalized to other secretory cell types.  Moreover, the mechanism by which 
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the autophagy pathway or autophagy genes contribute to vesicle trafficking and secretion 
is of great interest. 
 
 This thesis will explore the functions of autophagy genes in primary mouse B and 
T lymphocytes and osteoclasts, three cell types with physiologically relevant functions 
that can be studied in vivo and in vitro.  The life and death of lymphocytes is a tightly 
regulated process that allows rapid and massive expansion of cells followed by similarly 
drastic reduction over the course of an immune response, providing a well-studied system 
to examine the function of autophagy genes in cell survival and development.  Osteoclast 
function is dependent upon temporally and spatially regulated secretion, allowing 
mechanistic studies of the function of autophagy genes in cell secretion.    
B Cell Subsets 
 B lymphocytes have a variety of functions in the immune response (reviewed in 
94), including the secretion of antibody, presentation of antigen95,96, and production of 
cytokines97,98.  B cells are classified into two subsets, B-1 and B-2, based on cell surface 
marker expression, developmental origin, and functional properties (reviewed in 99).  B-2 
B cells develop from hematopoietic stem cells in the bone marrow, undergoing a series of 
maturational stages that can be defined by expression of cell surface markers (Hardy 
fractions A-F)100.  B-2 B cells exit the bone marrow as immature cells that finish their 
development in the spleen as transitional B cells101.  The majority of B-2 B cells develop 
into follicular B cells, which are found in B cell follicles and respond to infection with 
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production of high-affinity antibodies (reviewed in 102).  B-2 B cells also develop into 
marginal zone B cells, which are located in the spleen and rapidly produce antibodies 
against blood-borne antigens (reviewed in 103). 
 B-1 B cells are part of the innate immune system and are located primarily in 
body cavities.  B-1 B cells are further subdivided into B-1a and B-1b subsets based on 
expression of the cell surface protein CD5.  Studies indicate that B-1a cells produce 
natural antibodies, defined as antibodies present in the serum before exposure to 
exogenous antigen (reviewed in 104).  Natural antibodies are important for early control of 
viral and bacterial infection105,106.  Unlike the spontaneous secretion of antibody by B-1a 
B cells, B-1b cells are induced to secrete antibody that is important for the clearance of 
pathogens107 (reviewed in 99).   
 The developmental origin of B-1 B cells is still controversial, with two competing 
models under study.  According to the selection model, B-1 and B-2 B cells are derived 
from a common progenitor that differentiates into one of the two lineages based on 
antigen selection at the transitional stage (reviewed in 108).  Alternatively, the lineage 
model proposes that B-1 and B-2 B cells originate from distinct progenitors.  The lineage 
model is supported by the recent identification of a B-1 B cell progenitor in fetal and 
adult tissues109.  It has also been suggested that B-1a and B-1b B cells have distinct 
progenitors and lineages110. 
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The Role of Autophagy Genes in B Cells 
 There is little known about the functions of autophagy and autophagy genes in B 
cells.  Two papers demonstrate that autophagy is a constitutive process in human B cell 
lines61,60, which the authors suggest may be involved in bringing cytosolic antigens to 
load onto MHC class II.  B cell receptor (BCR) signaling stimulates autophagy111, which 
is important for synergistic signaling of the BCR and Toll-like receptor 9 (TLR9), an 
innate immune receptor that recognizes unmethylated DNA 112.  Together these studies 
suggest that autophagy is a constitutive process that can be upregulated in B cells and that 
may be important for antigen presentation and B cell signaling.   
T Cell Survival 
 T cells are key regulators and effectors of the immune response responsible for 
both the clearance of pathogens and, when dysregulated, autoimmune disease.  For this 
reason, T cell homeostasis is a tightly regulated process.  T cells differentiate from the 
pluripotent hematopoietic stem cell in the bone marrow and complete their development 
in the thymus, where they undergo a series of well-defined stages defined by cell surface 
marker expression and T cell receptor (TCR) gene rearrangement (reviewed in 113).  
Mature, naïve T cells then emigrate from the thymus to the periphery, where their 
survival is regulated by cytokines and signals through the T114,115,116,117 (reviewed in 118).  
Previously activated T cells can die by a process known as activation-induced cell death 
(AICD) via signaling through TNF receptor superfamily members such as CD95/Fas and 
TNFR1116,119 (reviewed in 120).  Activated cells can also die by neglect when they do not 
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receive appropriate survival factors, known as activated cell-autonomous death (ACAD), 
which is thought to be mediated through the balance of pro- and anti-apoptotic Bcl-2 
family members121 (reviewed in 118,120). 
 ROS regulate T cell activation and homeostasis by modulating cell signaling, 
proliferation, and apoptosis122,123,124 (reviewed in 75,125).  ROS are involved in the 
upregulation of FasL following T cell activation, a process important for AICD126,127.  
ROS also downregulate expression of the anti-apoptotic molecule Bcl-2 in activated T 
cells, resulting in ACAD128,129. 
The Role of Autophagy Genes in T cells 
 Autophagy plays a critical role in the development and survival of T lymphocytes.  
This process is constitutively active in the thymus130,4 and upregulated after T cell 
activation131,132.  Multiple studies suggest that autophagy and autophagy genes can 
contribute to T cell death, such as after growth factor withdrawal131 or in the context of T 
cells lacking FADD activity, caspase-8, or Irgm-1133,134.  T cells exposed to the env 
protein of HIV also undergo cell death that can be blocked by inhibiting autophagy135.  
However, deletion of the autophagy gene Atg5 in primary T lymphocytes results in 
decreased survival132.  In summary, autophagy genes may be important for cell survival 
in normal T cells, but excessive induction of autophagy or autophagy in the context of 
certain genetic deletions may serve as a pro-death mechanism.   
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Osteoclast Function 
Osteoclasts are the primary cell responsible for bone degradation.  The 
coordination of the bone resorption activity of osteoclasts with the bone forming activity 
of osteoblasts is critical for the maintenance of skeletal integrity and calcium homeostasis 
(reviewed in 136).  Diseases disrupting osteoclast activity result in osteopetrosis, an 
increase in bone mass.  In contrast, increased osteoclast activity reduces bone mass, 
resulting in osteopenia and osteoporosis (reviewed in 137).       
Osteoclasts differentiate from cells of the monocyte lineage by fusion of 
precursors into a polykaryon under the influence of M-CSF and RANKL138 (reviewed in 
137).  The osteoclast is activated and polarizes after recognizing the bone substrate via 
signaling through cell surface molecules such as the αvβ3 integrin139 (reviewed in 140,137) 
(Fig. 1-2).  One of the first steps is the formation of a sealing zone, an area of tight 
adherence of the osteoclast to the bone matrix.  The extracellular mediators of this 
junction are still in question, but intracellularly there is an accumulation of 
microfilaments that form an actin ring.  To degrade bone, osteoclasts deliver vesicles 
containing lysosomal enzymes to the interior of the actin ring where they fuse with the 
plasma membrane, forming a region of membrane folds termed the ruffled border 
(reviewed in 141).  Bone degradation by osteoclasts requires the action of hydrogen ions 
and lysosomal enzymes.  Hydrogen ions are important for the demineralization of bone 
and are secreted by the action of the vacuolar H+ ATPase142,143,144.  The hydrogen ions 
are generated by a carbonic anhydrase enzyme in the cell, which combines water and 
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carbon dioxide to generate hydrogen ions and biocarbonate145 (reviewed in 137).  
Electrical neutrality of the cell and resorption pit is maintained by a chloride/bicarbonate 
pump in the basolateral cell surface (away from the bone) and a chloride channel in the 
apical surface (against the bone)146 (reviewed in 137).  After demineralization, enzymes 
such as cathepsin K degrade the organic matrix of bone147,148.  The degraded collagen 
fragments are transcytosed across the cell for exocytosis at the basolateral side of the 
osteoclast opposite the bone149,150.   
A number of lines of evidence suggest that the vesicles fusing with the plasma 
membrane are lysosomes, often called "secretory lysosomes" (reviewed in 151).  First, 
lysosomal proteins such as LAMP1, LAMP2, and the vacuolar H+ ATPase are localized 
to the plasma membrane at the ruffled border152,153,144.  Second, Rabs associated with late 
endosomes (Rab7 and Rab9) have also been localized on the ruffled border152,153,154, and 
Rab7 has been shown to be important for formation of the ruffled border155.  Finally, 
lysosome-associated enzymes such as cathepsin K are found in the extracellular bone 
resorption pit156.  It has also been shown that small, coated vesicles from the trans-Gogli 
network containing lysosomal enzymes traffic to the ruffled border and fuse with the 
plasma membrane157, thus the exact nature of the vesicle or vesicles necessary for ruffled 
border formation and bone degradation is unclear. 
The molecular mechanisms responsible for the directional secretion of vesicles in 
osteoclasts are poorly understood.  Rab7 is an important GTPase for vesicular trafficking 
of late endosomes39 and maturation of autophagosomes40,41,42 and is important for 
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formation of the ruffled border and localization of the vacuolar H+ ATPase in 
osteoclasts155.  Rab3D, which localizes to the trans-Golgi network, and Synaptotagmin 
VII, an accessory molecule of vesicle fusion proteins involved in lysosome exocytosis158, 
are two additional molecules important for osteoclast secretion159,160.  The machinery of 
vesicle fusion and the signals targeting vesicles to the ruffled border are still unknown. 
Experimental Systems  
 Given our goal to understand the role of autophagy genes in B cells, T cells, and 
osteoclasts, we generated mice lacking Atg5 or Atg7 in these cell types to study the in 
vivo phenotypes and serve a source of primary cells for in vitro studies.  Knockout mice 
lacking either Atg5 or Atg7 are born in mendelian ratios but die within the first day of 
life1,2.  Because of the neonatal lethality, mice containing loxP-flanked Atg5 and Atg7 
genes have been generated to allow cell-type specific deletion of these essential 
autophagy genes1,78.  We bred mice with two copies of a loxP-flanked (“floxed”) Atg5 or 
Atg7 gene with mice expressing the Cre recombinase under control of a B cell specific 
promoter (CD19-Cre)161, T cell specific promoter (Lck-Cre)162, or monocyte/granulocyte 
specific promoter (LyzM-Cre)163.  These mice should express the Cre recombinase in B 
cells, T cells, or osteoclasts, resulting in the cell-type specific deletion of the Atg5 or Atg7 
floxed alleles.  We also reconstituted the hematopoietic compartment of irradiated Rag1-/- 
or CD45.1 mice with fetal liver stem cells from Atg5-/- pups, giving us a second in vivo 
system to study the effects of Atg5 deletion in B and T cells. 
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Figure 1-1.  Overview of the mammalian autophagy pathway 
The autophagy pathway can be divided into four stages.  Stage 1 - vesicle nucleation to 
form an isolation membrane, requires the activity of a class III PI3K complex.  Stage 2 - 
expansion and closure of the isolation membrane around cytoplasm to form a double-
membrane bound autophagosome, requires two highly conserved ubiquitin-like 
conjugation systems that function to conjugate LC3 to phosphatidylethanolamine.  Stage 
3 - fusion of the autophagosome with the endo-lysosomal pathway.  Stage 4 - breakdown 
of vesicle contents in the lysosome.  Figure adapted from Virgin and Levine, 2009164. 
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Figure 1-2.  Function of the bone-resorbing osteoclast 
Osteoclast bone resorption requires activation of the osteoclast by recognition of the bone 
substrate via receptors such as the αvβ3 integrin.  Vesicles containing cathepsin K (Ctsk), 
vacuolar H+ ATPases (red arrow), and chloride channels (pink box) are inserted into the 
plasma membrane against the bone, forming a ruffled border.  Hydrogen ions are pumped 
into the resorption pit, generated by the action of carbonic anhydrase in the cell.  
Electrical neutrality in the cell and resorption pit is maintained by the chloride channel 
and chloride-bicarbonate exchanger.  After demineralization of the bone, the organic 
matrix is degraded by the action of cathepsin K and other enzymes.  Figure adapted from 
www.biology-online.org. 
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CHAPTER 2 
The Autophagy Gene Atg5 Plays an Important Role in B Cell 
Development and B-1a B Cell Maintenance 
 
 
 
 
 
Portions of this chapter are excerpted from: 
Miller BC, Zhao Z, Stephenson LM, Cadwell K, Pua HH, Lee HK, Mizushima NN, 
Iwasaki A, He YW, Swat W, Virgin HW 4th. The autophagy gene ATG5 plays an 
essential role in B lymphocyte development.  Autophagy. 2008 Apr 1;4(3):309-14. 
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Abstract 
Macroautophagy (herein autophagy) is an evolutionarily conserved process, 
requiring the gene Atg5, by which cells recycle organelles and long-lived proteins.  Here 
we show that Atg5 is required for B cell development in the bone marrow and the 
homeostasis of B-1a B cells.  Deletion of Atg5 in B lymphocytes using Cre-LoxP 
technology or repopulation of irradiated mice with Atg5-/- fetal liver progenitors resulted 
in a dramatic reduction in B-1a B cells in the peritoneum.  Atg5-/- progenitors exhibited a 
significant defect in B cell development at the pro- to pre-B cell transition, although a 
proportion of pre-B cells survived to populate the periphery.  Once in the periphery, 
Atg5-deficient peripheral B-2 B cells have no increase in markers of cell death and 
proliferate normally in vitro.  In contrast, inefficient B cell development in the bone 
marrow was associated with increased cell death, indicating that Atg5 is important for B 
cell survival during development.  We conclude that Atg5 is differentially required at 
discrete stages of development in distinct, but closely related, cell lineages.  
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Introduction 
 Autophagy has been reported to be a constitutive process in B cells that is 
important for antigen presentation and signaling1,2,3,4, but the function of autophagy genes 
in B cell survival and development are unknown.  To address these questions we deleted 
the essential autophagy gene Atg5 in primary B lymphocytes in vivo. 
 Developing B cells subsets can be identified in the mouse by expression of cell 
surface markers that correspond to gene rearrangements in the immunoglobulin locus 
(reviewed in 5).  One convenient method to distinguish developing B cells is by the Hardy 
classification system6.  The early fractions of developing B cells (fractions A-C, also 
known as pre-pro-B cells and pro-B cells) express CD43 and undergo rearrangement of 
the heavy chain locus.  The final CD43+ fraction, fraction C', expresses the heavy chain 
on the cell surface with the surrogate light chain.  Cells that have successfully rearranged 
the heavy chain divide and lose expression of CD43.  These cells make up the final 
developing B cell fractions in the bone marrow (fractions D and E).  Fraction D, also 
known as late pre-B cells (fraction C' are considered early pre-B cells), rearranges the 
light chain locus such that fraction E is the first developing B cell to express the complete 
immunoglobulin on the cell surface6.  Fraction E cells leave the bone marrow to finish 
their development in the spleen, but can return as mature B cells (fraction F).  In the 
spleen, immature B cells go through at least two transitional stages before finishing their 
maturation (reviewed in 7).  These stages can be defined by cell surface expression of 
IgM and IgD8. 
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 Mature B cells are divided into two major classifications: B-1 and B-2 B cells.  B-
1 B cells are further subdivided into B-1a and B-1b cells based on expression of the 
marker CD5 and functional properties (reviewed in 9).  B-2 B cells are subdivided into 
marginal zone and follicular B cells, two functionally distinct classes that differ in their 
expression of CD21 and CD23 (reviewed in 10).  Together, these B cells produce 
antibodies important from initial infection to long-lived memory responses.  
 In this chapter we evaluated the role of Atg5 in B cell development and 
homeostasis.  While B-2 B cells can be generated from Atg5-/- precursor cells and 
populate peripheral lymphoid organs, Atg5 was required for efficient development from 
pro- to pre-B cells in the bone marrow.  The absence of Atg5 was associated with a 
significant increase in the death of Hardy fraction D-F B cells.  In addition to its function 
during development, Atg5 is important for the maintenance of mature B-1a B cells. 
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Results 
Atg5 is required to maintain normal numbers of peripheral B-1 B cells 
To study the role of the autophagy gene Atg5 in B cells, we generated Atg5-/- 
chimeric mice.  Atg5-/- or wild-type fetal liver cells were used to reconstitute irradiated 
Rag1-/- hosts11.  In the peritoneum, Atg5-/- reconstituted mice had decreased numbers of 
B-1a B cells (16 fold), B-1b B cells (4 fold), and B-2 B cells (6 fold) (Fig. 2-1).  Lymph 
node B-2 B cell repopulation was equivalent between wild type and Atg5-/- chimeras, 
while both B-1 and B-2 B cell numbers were decreased in the spleen approximately 50% 
(B-2 B cells: p = 0.017; B-1 B cells: p = 0.035).  The proportion of transitional, mature 
follicular, and marginal zone B-2 B cells in the spleen were normal, however (Fig. 2-2).  
This data indicates that Atg5 has a role in maintaining both B-1 and B-2 B cell numbers 
in the periphery, with a more dramatic role in B-1a B cells. 
 
Atg5 is required for the survival of pre-B cells 
The observed decrease in peripheral B cells in Atg5-/- chimeras could be due to a 
decrease in B cell production in the bone marrow or an increase in cell death in the 
periphery.  To test the first hypothesis, we evaluated the stages of bone marrow B cell 
development in Atg5-/- versus wild-type fetal-liver reconstituted irradiated CD45.112 and 
Rag1-/- hosts (Fig. 2-3 and 2-4).  FACS analysis of donor pro-B cells from CD45.1 
chimeras revealed no significant differences in cell numbers of fraction A-C’ developing 
B cells (Fig. 2-3).  In contrast, analysis of Atg5-/- Rag1-/- chimeric mice revealed a 
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decrease in Hardy fractions D (3.7 fold reduction), E (8.3 fold reduction), and F (11.8 
fold reduction) (Fig. 2-4).  CD45.1 chimeras had a similar deficiency of fractions D, E, 
and F (data not shown).  This data indicates that Atg5 has a critical role in the final stages 
of bone marrow B cell development.  We hypothesized that Atg5 may be required for B 
cell survival after the pro-B cell stage of development.  FACS analysis of freshly isolated 
bone marrow cells revealed a greater percentage of fraction D-F cells were dead or dying 
in Atg5-/- Rag1-/- chimeric mice compared with control mice as measured by Annexin-V 
and 7-AAD (Fig. 2-5; Atg5+/+: 3.2 ± 0.8%; Atg5-/-: 22.2 ± 5.3%; p = 0.0056).  We 
conclude that Atg5 is required as a survival factor for developing B cells after the pro-B 
to pre-B cell transition in the bone marrow. 
 
B-2 B cells survive normally in the periphery without Atg5 
 Although the role of Atg5 in B cell development could explain the deficiency in 
peripheral Atg5-/- B cells, we could not rule out that Atg5 is also required for B cell 
survival in the periphery.  To determine if Atg5 is required for B cell homeostasis without 
the confounding role of Atg5 in B cell development, we expressed Cre recombinase in the 
B cells of mice containing two copies of a knock-in Atg5 gene in which LoxP sites were 
inserted flanking the third exon [Atg5flox/flox]13.  B cell specific expression of Cre was 
obtained using the B cell specific CD19 promoter [CD19-Cre]14.  Although the 
expression of Cre from the CD19 promoter effectively deletes loxP-flanked DNA in more 
than 90-95% of mature B cells, it results in incomplete DNA rearrangement in pre-B 
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cells14.  Given that the CD19-Cre construct replaces the wild-type CD19 gene and could 
therefore have an effect on B cells independent of the deletion of Atg515, all mice were 
bred to have only one copy of CD19-Cre.  Furthermore, we used Atg5 wild-type CD19-
Cre+ mice (herein CD19-Cre mice) as a control in subsequent experiments.  
We confirmed rearrangement of the Atg5flox alleles specifically in CD19+ B cells 
from Atg5flox/flox-CD19-Cre+ mice using PCR (data not shown).  In addition, B cells from 
Atg5flox/flox-CD19-Cre+ mice did not express detectable ATG5-ATG12 conjugate and 
failed to convert LC3-I to LC3-II (Fig. 2-6).  Splenic B cells from control Atg5flox/flox-
CD19-Cre- mice expressed ATG5-ATG12 conjugate and converted LC3-I to LC3-II 
(Fig. 2-6).  We conclude that Atg5 is specifically deleted from peripheral CD19+ B 
lymphocytes in our mice and that, as expected16, loss of Atg5 inhibits classical 
macroautophagy as shown by loss of the capacity to generate LC3-II from LC3-I.   
We next determined whether Atg5 is required to maintain normal numbers of B 
cells in peripheral tissues of adult mice.  Importantly, we observed no difference in B cell 
development in fractions A through E in Atg5flox/flox-CD19-Cre+ mice (data not shown).  
There was a twofold decrease in fraction F cells in Atg5flox/flox-CD19-Cre+ mice 
compared with Atg5flox/flox-CD19-Cre- controls (Atg5flox/flox-CD19-Cre-: 1.6 ± 0.27 x 106; 
Atg5flox/flox-CD19-Cre+: 0.81 ± 0.16 x 106; p = 0.0243).  This was consistent with, 
although less severe than, the decrease in fraction F cells observed in chimeric mice.  
There was no decrease in fraction F cells in CD19-Cre mice (data not shown).  In the 
periphery, Atg5flox/flox-CD19-Cre+ mice had normal numbers of B220+ B lymphocytes in 
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the spleen and lymph nodes, and IgM and IgD were expressed normally on these cells.  
The percentage and number of splenic and lymph node mature recirculating B cells and 
transitional B cells was comparable between Atg5flox/flox-CD19-Cre-, CD19-Cre, and 
Atg5flox/flox-CD19-Cre+ mice (Fig. 2-7).  As expected, there were no differences in the 
numbers of T cell subsets in the thymus or periphery in these mice (data not shown).  As 
more than 95% of splenic and nearly 100% of lymph node B cells are B-2 B cells9, it 
follows that B-2 B cell numbers are normal in the spleen and lymph node in the absence 
of Atg5.   
We next asked if Atg5 is required for B-2 B cell survival or proliferation.  To 
determine if Atg5 is required for B cell survival, we evaluated Annexin-V and 7-AAD 
staining of freshly isolated splenic and lymph node B220+ cells and observed no 
differences in the numbers of dead or dying B cells (data not shown).  We assessed 
proliferation by stimulating total splenocytes in vitro with LPS and measuring CFSE dye 
dilution.  Flow cytometry of the splenocytes after 72 hours revealed no difference in the 
ability of the Atg5-deficient B cells to divide in response to LPS (Fig. 2-8).  Together, 
this data suggests that Atg5 is not essential for the maintenance of B-2 B cell populations 
in the periphery and is not important for B-2 B cell survival or proliferation.  We 
hypothesize that the decrease in splenic B-2 B cells in Atg5-/- chimeric animals is due to 
the important role of Atg5 in pre-B cells during development.  
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Atg5 is required in a cell-intrinsic manner to maintain normal numbers 
of B-1a B cells 
In contrast to these findings for B-2 B cells, Atg5flox/flox-CD19-Cre+ mice showed 
a 5-fold decrease in the number of B-1a B cells in the peritoneum (Fig. 2-9; Atg5flox/flox-
CD19-Cre-: 4.5 ± 1.2 x 105; Atg5flox/flox-CD19-Cre+: 0.76 ± 0.19 x 105; p = 0.0079).  
There was no statistically significant difference in the number of B-1b or B-2 B cells in 
the peritoneum of Atg5flox/flox-CD19-Cre+ mice.  There was also no decrease in B-1a B 
cell numbers in CD19-Cre mice (Fig. 2-9).  One explanation for this finding would be 
that Atg5 is required for expression of CD5, a marker of B-1a B cells.  In the peritoneum, 
both B-1a and B-1b B cells are B220lo, IgMhi, IgDlo, and CD23-9.  We therefore analyzed 
expression of these additional markers on peritoneal B cells (Fig. 2-9B and 2-9C).  We 
found that Atg5flox/flox-CD19-Cre+ mice contained fewer B-1 B cells in the peritoneum 
than Atg5flox/flox-CD19-Cre- or CD19-Cre mice, confirming that the deficiency of B-1a B 
cells shown using CD5/B220 staining was not an artifact due to lack of CD5 expression 
in Atg5-deficient cells.  In addition, we confirmed that this deficiency is specific for B-1a 
B cells but not B-1b B cells (Fig. 2-9C).  We conclude that the requirement for Atg5 to 
maintain B-1a B cell numbers is cell-intrinsic since only B cells lack Atg5 in Atg5flox/flox-
CD19-Cre+ mice.   This suggests that the observed results in Atg5-/- chimeric mice may 
also be due to cell-intrinsic effects of Atg5 deficiency. 
 As B-1a B cells are responsible for the production of natural antibodies 
(reviewed in 9), we next measured natural antibody titers in these mice.  Anti-
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phosphocholine antibodies have been shown to be an important natural antibody for 
protection against Streptococcus pneumonia17.  Interestingly, there was no dramatic 
decrease in the levels of anti-phosphocholine IgM antibodies in the serum of Atg5flox/flox-
CD19-Cre+ mice (Fig. 2-10), despite the reduction in B-1a B cells in these animals.  We 
hypothesize that the remaining B-1a B cells in Atg5flox/flox-CD19-Cre+ mice produce 
sufficient quantities of natural antibody to compensate for the reduction in cell numbers. 
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Discussion 
In this chapter we demonstrate a critical role for the autophagy gene Atg5 in 
specific B cell developmental stages and lineages.  Atg5 is required for the efficient 
development and survival of pre-B cells in the bone marrow.  A few B-2 B cells survive 
this transition and are able to populate peripheral lymphoid tissues, where Atg5 does not 
seem to be required for their survival or proliferation.  In the absence of Atg5 there is also 
a dramatic reduction in peripheral B-1a B cells.   
The requirement for Atg5 in autophagy is clear16,18.  Therefore, we can safely 
conclude from our studies in Atg5flox/flox-CD19-Cre+ mice that autophagy is not required 
for the maintenance of peripheral B-2 B cell numbers.  However, Atg5 may have other 
roles in addition to its primary role in autophagy19.  ATG5 can be cleaved by calpain and 
gain pro-death activity20.  The protein can also interact with Fas-associated protein with 
death domain (FADD) to trigger autophagic cell death21.  We believe it unlikely that 
these pro-death roles of Atg5 are related to our findings in which Atg5 is required for the 
survival of B cells. 
 Our results, in conjunction with the Atg5-/- T cell characterization by Pua et al.12 
and our work in Chapter 3 of this thesis, demonstrate that Atg5 is differentially required 
in T cells versus B cells, two cell types from a common developmental lineage.  Recently 
it has been suggested that B-1a, B-1b, and B-2 B cells may develop from distinct cell 
lineages22,23.  Our results suggest that these distinct lineages have differential 
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requirements for Atg5 or Atg5-dependent autophagy.  In addition, our data suggests that 
Atg5 or autophagy is required at very specific stages in lymphocyte development. 
 We were surprised to find no decrease in anti-phosphocholine natural antibody 
titers in Atg5flox/flox-CD19-Cre+ mice.  We speculate that the reduction in B-1a B cell 
numbers is compensated by an increase in antibody production by the remaining cells.  
To test the ability of these mice to increase production of B-1a B cell derived antibodies, 
it would be interesting to stimulate these cells via immunization with Streptococcus 
pneumonia polysaccharides24.  We predict that Atg5flox/flox-CD19-Cre+ mice would have 
decreased anti-pneumococcal titers after stimulation compared with control mice due to 
the reduced numbers of B-1a B cells. 
 It is intriguing to speculate that the critical role for Atg5 in the maintenance of B-
1a B cells in the periphery and for efficient pro-B cell to pre-B cell transition during B-2 
B cell development in the bone marrow are related phenomena.   B-1a B cells maintain 
their numbers in the adult by self-renewal25.  We speculate that B-1a B cells lacking Atg5 
may not be able to self-renew efficiently resulting in decreased peripheral numbers.  In 
this case the effects of Atg5 on B-2 and B-1a B cells may reflect a critical role for Atg5 in 
survival during specific stages of cellular differentiation.  Given the importance of 
cytokines and growth factors in B cell development, this might be due to a role for Atg5 
in cytokine-driven differentiation or cell survival after growth factor withdrawal26.
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Figure 2-1.  B-1 B cells are deficient in Atg5-/- chimeric mice  
(A) Staining of peritoneal cells from Atg5+/+ and Atg5-/- Rag1-/- chimeric mice to identify 
B cell subsets: B-1a (CD5+, B220lo); B-1b (CD5-, B220lo); B-2 (CD5-, B220hi).  
Numbers indicate percentage of cells in each gate.  Data representative of at least seven 
mice from four independent experiments.  (B) Quantification of B-1 B cells from the 
peritoneum of Atg5+/+ and Atg5-/- Rag1-/- chimeric mice (Atg5+/+: n = 7; Atg5-/-: n = 6).    
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Figure 2-2.  No dramatic differences in the percentages of B-2 B cell 
splenic subsets in Atg5-/- chimeric mice 
IgM/IgD and CD21/CD23 staining of B220+ lymphocytes from the spleens of Atg5+/+ 
and Atg5-/- Rag1-/- chimeric mice to identify B cell subsets: MR, mature recirculating B 
cells (IgMlo, IgDhi); T1, transitional type 1 (IgMhi, IgDlo); T2, transitional type 2 (IgMhi, 
IgDhi) ; MZ, marginal zone B cells (CD21hi, CD23lo); FO, follicular B cells (CD21lo, 
CD23hi).  T1 gating includes marginal zone and splenic B-1 B cells.  Data representative 
of at least eight mice from four independent experiments. 
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Figure 2-3.  Atg5 is not required for the normal development of pro-B 
cells in the bone marrow 
(A) Flow cytometry of bone marrow cells from Atg5+/+ and Atg5-/- CD45.1 chimeric 
mice.  Cells were gated on CD45.2+, GR1-, Mac1-, and 7-AAD-.  B220+, CD43+ cells 
were further analyzed for expression of BP-1 and CD24.  Fraction A (B220+, CD43+, 
CD24-, BP-1-); Fraction B (B220+, CD43+, CD24+, BP-1-); Fraction C-C' (B220+, 
CD43+, CD24+, BP-1+).  Data representative of at least four mice from four independent 
46 
experiments.  (B) Quantification of Hardy fractions A-C’ in Atg5+/+ and Atg5-/- CD45.1 
chimeric mice (n = 4 for each group).   
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Figure 2-4.  Atg5 is required for normal development of pre-B cells in 
the bone marrow 
(A) Flow cytometry of bone marrow cells from Atg5+/+ and Atg5-/- Rag1-/- chimeric mice.  
Cells were gated on B220+, CD43- and analyzed for expression of IgM.  Fraction D 
(B220+, CD43-, IgM-); Fraction E (B220+, CD43-, IgMhi); Fraction F (B220hi, CD43-, 
IgMlo).  Data representative of at least eight mice from four independent experiments.  
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(B)) Quantification of Hardy fractions D-F in Atg5+/+ and Atg5-/- Rag1-/- chimeric mice (n 
= 8 for each group).   
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Figure 2-5.  A greater percentage of Atg5-deficient developing pre-B 
cells are Annexin-V+ and 7-AAD+ compared with control cells 
Flow cytometry of freshly isolated bone marrow cells from Atg5+/+ and Atg5-/- Rag1-/- 
chimeric mice.  Cells were gated on B220+, CD43- and analyzed for cell death by 
Annexin-V and 7-AAD.  Data representative of at least six mice from three independent 
experiments. 
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Figure 2-6.  B-2 B cells from Atg5flox/flox-CD19-Cre+ mice do not express 
detectable levels of ATG5 
Immunoblotting with antibodies against ATG5 and LC3 from CD19+ (B) and CD19- 
(Other) bead-purified splenocytes.  Representative blot of three independent experiments 
shown.   
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Figure 2-7.  No dramatic differences in the percentages of spleen or 
lymph node B-2 B cells subsets in Atg5flox/flox-CD19-Cre+ mice 
IgM and IgD staining of B220+ lymphocytes from the spleen and lymph nodes.  MR, 
mature recirculating B cells (IgMlo, IgDhi); T1, transitional type 1 (IgMhi, IgDlo); T2, 
transitional type 2 (IgMhi, IgDhi).  T1 gating includes marginal zone and splenic B-1 B 
cells.  Data representative of at least ten mice from five independent experiments. 
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Figure 2-8.  Atg5-deficient B-2 B cells do not have a defect in 
proliferation to LPS 
(A) Total splenocytes from Atg5flox/flox-CD19-Cre+ and Atg5flox/flox-CD19-Cre- mice were 
labeled with CFSE and plated with different concentrations of LPS for 72 hours.  B cells 
were gated by forward and side scatter and B220 staining.  Representative FACS plots 
from one of three independent experiments, 6 mice of each genotype.  (B) Quantification 
A
B
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of the percentage of CFSElow cells, representing cells that had divided at least once, from 
2-3 independent experiments, representing 4-6 mice of each genotype. 
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Figure 2-9.  B-1a B cells are deficient in the peritoneum of Atg5flox/flox-
CD19-Cre+ mice 
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(A-B) Staining of peritoneal cells to identify B cell subsets: B-1a (CD5+, B220lo, CD23-, 
IgMhi, IgDlo); B-1b (CD5-, B220lo, CD23-, IgMhi, IgDlo); B-2 (CD5-, B220hi, CD23lo, 
IgMlo, IgDhi).  All data is representative of at least five mice from three independent 
experiments.  (C) B-1 B cells are gated by B220lo, CD23- and separated into B-1a and B-
1b B cells by expression of CD5. 
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Figure 2-10.  No significant decrease in anti-phosphocholine natural 
antibody titers in Atg5flox/flox-CD19-Cre+ mice 
Enzyme-linked immunosorbent assay (ELISA) to detect anti-phosphocholine IgM 
antibodies in serum from Atg5flox/flox-CD19-Cre+, Atg5flox/flox-CD19-Cre-, and Rag1-/- 
mice.  Figure 2-10A shows one representative experiment.  There was little absorbance in 
the no antigen control wells plated with the highest dilution of serum, indicating little 
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non-specific binding of antibody.  Figure 2-10B shows data pooled from 2-3 experiments.  
To pool the data across experiments, the average absorbance readings for each serum 
dilution were normalized to the average of the no antigen negative control reading for 
that mouse.  There are no statistically significant differences between Atg5flox/flox-CD19-
Cre+ and Atg5flox/flox-CD19-Cre- samples in the linear range of the dilution series (1/200 – 
1/20 dilution).  n = 9 for Atg5flox/flox-CD19-Cre mice, n = 4 for Rag1-/- mice. 
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Materials and Methods 
Mice  ATG5-/- and ATG5flox/flox mice have been previously described27,13.  C.129P2-
Cd19tm1(cre)Cgn/J (CD19-Cre) mice,  B6.129S7-Rag1tm1Mom/J (Rag1-/-) mice, and 
B6.SJL-Ptprca Pepcb/BoyJ (CD45.1) mice were obtained from The Jackson Laboratory 
(Bar Harbor, ME).  In most experiments we compared ATG5flox/flox-CD19-Cre+ to CD19-
Cre mice and littermate ATG5flox/flox-CD19-Cre- mice.  Mice were genotyped as 
described13, with the Atg5 gene detected with the primers exon3-1 
(GAATATGAAGGCACACCCCTGAAATG), short2 (GTACTGCATAATGGTTTAAC 
TCTTGC), and check2 (ACAACGTCGAGCACAGCTGCGCAAGG) using PCR [94°C 
(4 min); 30 cycles of 94°C (30sec), 60°C (30sec), 72°C (1 min); 72°C (5min)].   The Cre 
gene was detected with primers cre1 (AGGTTCGTTCACTCATGGA) and cre2 
(TCGACCAGTTTAGTTACCC) using PCR [94°C (4 min); 25 cycles of 94°C (30sec), 
60°C (30sec), 72°C (1 min); 72°C (5min)].  CD45.1 chimeric mice were generated as 
described12.  For the generation of Rag1-/- chimeric mice, day 15.5-18.5 Atg5+/- x Atg5+/- 
fetuses were harvested and genotyped with the REDExtract-N-AmpTM Tissue PCR Kit 
(Sigma-Aldrich, St. Louis, MO).  Sublethally irradiated (600 rad) Rag1-/- hosts were 
injected with cells from one-fourth of a fetal liver.  Chimeric mice were analyzed at least 
6 weeks after reconstitution.  All animal studies were performed in accordance with 
institutional policies for animal care and usage at the Washington University School of 
Medicine. 
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Flow cytometry  Single-cell suspensions were prepared from the bone marrow, lymph 
nodes, spleens, and thymi while peritoneal cells were harvested by lavage28.  Cells were 
stained and data collected on a FACSCalibur cytometer (BD Biosciences, San Jose, CA) 
for analysis using FlowJo software (TreeStar, Ashland, OR).  Antibodies against IgM, 
IgD, TCRβ, B220, BP-1, CD4, CD5, CD8, CD19, CD21, CD23, CD24, and CD43 were 
from BD Biosciences (San Jose, CA), eBioscience (San Diego, CA), or Southern Biotech 
(Birmingham, AL).  Biotinylated antibodies were detected with streptavidin-PE-Cy7 or 
streptavidin-APC (BD Biosciences, San Jose, CA).  Annexin-V and 7-AAD staining (BD 
Biosciences, San Jose, CA) was performed as per the manufacturer’s instructions except 
that DMEM was used in place of 1x Binding Buffer.  All samples were gated by forward 
and side scatter on lymphocyte populations for analysis. 
 
Immunoblots  B cells were purified using CD19-conjugated microbeads (Miltenyi, 
Auburn, CA).  CD19+ purified B cells and CD19- cells that did not bind to CD19-
conjugated magnetic beads were lysed in 2x Laemmli buffer and subjected to 
immunoblotting using antibodies specific for ATG518 (gift of N. Mizushima, Toyko 
Medical and Dental University, Tokyo, Japan) (1:1000 dilution),  LC3 (Novus 
Biologicals, Littleton, CO) (1:3000 dilution), and β-actin (Sigma-Aldrich, St. Louis, MO) 
(1:5000 dilution).  Immunoblots were developed with HRP-conjugated secondary 
antibodies (Jackson Immunoreseach Laboratories, West Grove, PA) (1:10,000 dilution) 
and visualized by chemiluminescence (Amersham Biosciences, Pittsburgh, PA). 
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Enzyme-linked immunosorbent assay (ELISA) Atg5flox/flox-CD19-Cre+, 
Atg5flox/flox-CD19-Cre-, and Rag1-/- mice were bled by cardiac puncture.  96-well 
Immulon 2HB flat-bottom plates (Fisher Scientific, Pittsburgh, PA) were coated with 
10ug/mL of phosphocholine-BSA (Biosearch Technologies, Novato, CA) or 3% bovine 
serum albumin (BSA) overnight at 4°C.  Wells were blocked with 3% BSA (Sigma, St. 
Louis, MO) for at least 1 hour at room temperature then washed.  Serum was plated in 
triplicate at dilutions starting at 1:10 or 1:20 and left for 1 hour at room temperature.  
Plates were washed and 1:1000 anti-IgM antibody conjugated to HRP (Southern Biotech, 
Birmingham, AL) was added for 1 hour at room temperature.  After a final wash, ABTS 
(2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) substrate with 1:1000 dilution of 
hydrogen peroxide was added to each well for 15 minutes before the reaction was 
stopped by 0.2N phosphoric acid.  Plates were read at 405nm. 
 
B cell proliferation  Single cell suspensions of red blood cell-lysed splenocytes were 
made from Atg5flox/flox-CD19-Cre+ and Atg5flox/flox-CD19-Cre- mice.  Cells were 
incubated with 1µM CFSE (Invitrogen, Carlsbad, CA) for 15 minutes and washed.  106 
cells were plated in 24-well plates with the indicated concentrations of LPS (Sigma, St. 
Louis, MO).  After 72-84 hours the cells were stained with anti-B220 antibody (BD 
Biosciences, San Jose, CA) and analyzed by flow cytometry. 
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Statistical analyses  All data were analyzed with Prism software (GraphPad, San 
Diego, CA) using two-tailed unpaired t tests.  Error bars represent SEM.   
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CHAPTER 3 
Autophagy Genes are Critical for Homeostasis and 
Mitochondrial Maintenance in Primary T Lymphocytes 
 
 
Portions of this chapter are excerpted from: 
Stephenson LM, Miller BC, Ng A, Eisenberg J, Zhao Z, Cadwell K, Graham DB, 
Mizushima NN, Xavier R, Virgin HW, Swat W. Identification of Atg5-dependent 
transcriptional changes and increases in mitochondrial mass in Atg5-deficient T 
lymphocytes.  Autophagy. 2009 Jul;5(5):625-35.  
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Abstract 
 Autophagy is implicated in many functions of mammalian cells such as organelle 
recycling, cell survival, and differentiation, and is essential for the maintenance of T and 
B lymphocytes.  Here, we demonstrate that autophagy is a constitutive process during T 
cell development.  Deletion of the essential autophagy genes Atg5 or Atg7 in T cells 
resulted in decreased thymocyte and peripheral T cell numbers, and Atg5-deficient 
peripheral T cells had an increase in a marker of cell death.  We employed functional-
genetic and integrative computational analyses to elucidate specific functions of Atg5 in 
developing T-lineage lymphocytes.  Our whole-genome transcriptional profiling 
identified a set of 699 genes differentially expressed in Atg5-deficient and Atg5-sufficient 
thymocytes (Atg5-dependent gene set).  Strikingly, the Atg5-dependent gene set was 
dramatically enriched in genes encoding proteins associated with the mitochondrion.  In 
support of a role for autophagy in mitochondrial maintenance in T lineage cells, the 
deletion of Atg5 led to increased mitochondrial mass in peripheral T cells.  We also 
observed a correlation between mitochondrial mass and Annexin-V staining in peripheral 
T cells.  We propose that autophagy is critical for mitochondrial maintenance and T cell 
survival.  We speculate that, similar to its role in yeast or mammalian liver cells, 
autophagy is required in T cells for the removal of damaged or aging mitochondria which 
contribute to cell death in autophagy-deficient T cells.  
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Introduction 
 In Chapter 2 we described the roles of Atg5 in B lymphocyte development and 
homeostasis.  Given our interest in the cell-type specificity of autophagy genes, we next 
chose to study these genes in T lymphocytes, a closely related cell lineage.  The functions 
of autophagy and autophagy genes are not well understand in T lymphocytes, with 
studies reporting both a pro-survival and pro-death role for autophagy1,2,3,4,5.   
 Soon after we initiated these studies, Pua et al. published the first report of the 
role of the essential autophagy gene Atg5 in primary T lymphocytes5.  They demonstrate 
that Atg5 is essential for T cell survival and proliferation using reconstitution of irradiated 
hosts with Atg5-/- fetal liver-derived stem cells.  Total thymocyte numbers are reduced in 
these chimeras.  There are striking decreases in CD4+ and CD8+ T cell numbers in 
peripheral lymphoid tissues, with an increase in the percentage of Annexin-V+ cells.  
Finally, Atg5-/- T lymphocytes have a dramatically reduced ability to proliferate after 
TCR stimulation5.  We decided to confirm their findings and explore some of the 
mechanistic questions raised by the phenotype that they reported.  First, is the observed 
phenotype due to a non-autophagy function of Atg5?  Second, are there abnormalities in 
Atg5-deficient T cells that might suggest a reason why there are fewer cells in vivo? 
 Autophagy is important for the degradation of damaged and excess 
mitochondria6,7,8,9.  Mitochondria have a critical role in T cell survival and activation, 
functioning in activation-induced signaling pathways and providing ATP and metabolites 
important for growth of the cell10 (reviewed in 11).  Mitochondria also contribute to T cell 
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death.  Mitochondria are an important source of reactive oxygen species (ROS), which 
sensitize T cells to AICD and ACAD12,13,14,15,16.  In addition, the balance of pro- and anti-
apoptotic Bcl-2 family members regulates release of the pro-apoptotic factor cytochrome 
c from mitochondria, initiating cell death (reviewed in 17).  Interestingly, an increase in 
mitochondrial mass in T cells has been associated with increased sensitivity to apoptosis 
in HIV-specific CD8+ T cells18.  Because of the function of autophagy in the regulation 
of mitochondria and the importance of mitochondria in T cell survival and death, we 
hypothesized that mitochondria may accumulate in Atg5-deficient T lymphocytes and 
contribute to T cell death. 
  Here we demonstrate that autophagy is a constitutive process in developing and 
mature T cells and that the essential autophagy genes Atg5 and Atg7 are required for 
thymocyte and peripheral T cell homeostasis.  In collaboration with Dr. Ramnik Xavier's 
group, we identify a thymocyte-specific transcriptional signature associated with 
deficiency of Atg5 in T cells and provide evidence that Atg5 is required for regulating 
mitochondrial mass in peripheral T cells.  Finally, we find a correlation between 
increased mitochondrial mass and increased Annexin-V staining in T cells, suggesting 
that abnormal mitochondria contribute to cell death in Atg5-deficient T cells. 
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Results 
Atg5 and Atg7 are required for the maintenance of developing and 
mature T lymphocytes 
 As a first step to understand the role of autophagy in T cells, we measured the 
levels of LC3-II as one marker of autophagic activity in developing and mature T lineage 
cells.  We sorted thymic and peripheral T lineage subsets and probed the lysates with 
anti-LC3 antibodies.  We observed robust LC3-II bands in all T cell subsets, indicating 
that autophagy is an active process in all stages of T cell development (Fig. 3-1A).  To 
confirm that autophagy is an ongoing process in T cells, we cultured thymoyctes for 4 
hours in the presence of increasing concentrations of chloroquine.  Chloroquine results in 
an accumulation of LC3-II in actively autophagic cells19,20.  As expected, LC3-II levels 
increased in a chloroquine dose-dependent manner (Fig. 3-1B), indicating that autophagy 
was ongoing in these cells.  
 Pua et al. reported that the essential autophagy gene Atg5 is essential for normal T 
cell homeostasis5, however the mechanism by which Atg5 controls T cell survival and/or 
proliferation remains unknown.  To address these issues, we generated two different 
mouse models to delete Atg5 in T cells.  First, we used recombination activating gene 
(Rag)-1-deficient complementation21,5,22 with E15.5-18.5 fetal liver cells from Atg5-/- or 
Atg5+/+ embryos23.  As an alternative approach, we generated Atg5-deficient T cells by 
breeding mice with conditionally targeted (floxed) Atg524 alleles to Lck-Cre transgenics 
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(Atg5flox/flox-Lck-Cre+).  In these experiments, Atg5flox/flox-Lck-Cre- mice were used as 
controls.   
 We first confirmed that T cells from these two mouse systems lack the ATG5 
protein.  Thymocyte lysates from Atg5-/- chimeras showed no detectable ATG5 protein 
expression (Fig. 3-2A).  We also were unable to detect LC3-II (Fig. 3-2A), indicating that 
classical macroautophagy is abrogated in the absence of ATG5 in T cells.  ATG5 levels 
were also reduced in Atg5flox/flox-Lck-Cre+ thymocytes (Fig. 3-2B); however residual 
levels of the protein were still detectable upon overexposure of the membrane, in spite of 
efficient recombination of the Atg5flox locus in thymocytes from Atg5flox/flox-Lck-Cre+ 
mice (data not shown).   
 We next analyzed the in vivo phenotype of Atg5-deficient T cells.  In agreement 
with the previously published report5, thymus cellularity of Atg5-deficient chimeric mice 
analyzed between 6 and 13 weeks post-fetal liver transfer was decreased approximately 
2.4-fold compared to controls (Table 3-1), although there were no discernable alterations 
in the percentages of CD4- CD8- double negative, CD4+ CD8+ double positive, CD4+ 
single positive, and CD8+ single positive cells (Fig. 3-3).  Moreover, both the 
percentages and total numbers of CD4+ and CD8+ T cells in the lymph nodes and 
spleens of Atg5-/- chimeric mice were decreased compared to Atg5+/+ chimeras (Fig. 3-3 
and Table 3-1).  A similar reduction in total numbers of thymocytes and peripheral T 
cells was observed in Atg5flox/flox-Lck-Cre+ mice compared to littermate controls (Fig. 3-3 
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and Table 3-1).  We conclude that the decrease in T cell numbers is a result of T cell-
intrinsic effects of the loss of Atg5. 
 It is possible that other functions of Atg5 apart from its role in autophagy may 
contribute to the phenotypic abnormalities of Atg5-deficient T cells25,26,27.  To address 
this issue, we deleted Atg7, another essential autophagy gene, from T cells using a 
conditional knockout approach similar to the one described above.  We bred mice with 
conditionally targeted (floxed) Atg728 alleles to Lck-Cre transgenics (Atg7flox/flox-Lck-
Cre+).  We observed reduced expression of ATG7 in Atg7flox/flox-Lck-Cre+ thymocytes 
by immunoblot analysis (Fig. 3-2C).  Similar to Atg5-/- chimeras and Atg5flox/flox-Lck-
Cre+ mice, total thymocyte and peripheral CD4+ and CD8+ T cell numbers were also 
reduced in Atg7flox/flox-Lck-Cre+ mice (Fig. 3-3 and Table 3-1).  Together these data 
suggest that autophagy is required for the maintenance of both developing and peripheral 
T lymphocytes. 
 
A role for Atg5 in mitochondrial maintenance and cell survival revealed 
by integrative computational analysis of whole-genome datasets   
 To obtain further insights into the functional pathways and networks through 
which Atg5 maintains the T cell compartment, we developed an analytical framework 
that integrates gene expression analyses of wild-type and Atg5-/- thymocytes from 
chimeric mice with diverse information extracted from various genomic screens and 
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databases including Gene Ontology (GO)29 for functional classification, HPRD30 for 
molecular interactions, HomoloGene31 for homology mapping of genes, and NCBI 
PubMed and MILANO for literature co-citation analyses31,32.  Whole-genome 
transcriptional profiling of Atg5-/- and Atg5+/+ thymocytes identified a set of 699 
differentially expressed genes (of which 259 genes were up-regulated and 440 down-
regulated in Atg5-/- thymocytes, as compared to wild-type thymocytes) (Fig. 3-4), 
permitting us to explore functional clusters within the set of differentially expressed 
genes and identify putative pathways and networks relevant to Atg5 function in the T 
lymphoid lineage.   
 To ascertain whether the Atg5-dependent gene set was statistically enriched for 
genes implicated in subcellular compartment-associated processes, we first analyzed their 
annotations in Gene Ontology (GO) cellular component categories.  Strikingly, the Atg5-
dependent gene set was dramatically enriched in genes encoding proteins associated with 
the mitochondrion (p=3.7x10-4) and nucleus (p=1.6x10-4) (Fig. 3-5).  The mitochondrion 
GO signature was particularly interesting given the suggested association between 
autophagy and mitochondrial maintenance.  We identified 64 mitochondrial-associated 
genes in the Atg5-dependent gene set (Fig. 3-5) from GO annotation and a recent 
comprehensive genome-wide survey of genes participating in mitochondrial-associated 
processes33.  This Atg5-dependent gene set GO signature strongly suggests a role for Atg5 
in mitochondrial function and/or maintenance.   
   As an additional computational strategy to elucidate potential connections of Atg5 
with mitochondrial function, we projected the Atg5-dependent gene set onto human 
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orthologs and generated a human protein-protein interaction network (Fig. 3-6).  The 
network was built by interrogating data from the HPRD database which contains protein-
protein interactions from the literature and from multiple large-scale interactome datasets.  
We next intersected this network analysis with GO cellular compartment annotations.  
This approach yielded mitochondrion-anchored subnetworks which we then extended by 
an additional degree of separation, thereby including non-Atg5-dependent gene set 
proteins that interacted with mitochondrion-associated Atg5-dependent gene set-encoded 
products.  We observed that many of these interacting partners are also annotated as 
mitochondrial related, further supporting the involvement of an enriched subset of Atg5-
dependent gene set in mitochondrial processes.   
 We next performed a literature (PubMed) co-citation analysis incorporating 
search terms such as ‘mitochondrial biogenesis’, ‘mitochondrial permeability’ and 
‘electron transport’ to gain additional insights into various mitochondrial processes or 
events in which the Atg5-dependent gene set might be involved (Fig. 3-7A).  We 
extended this analysis to include other terms associated with various general cellular 
processes (e.g. endocytosis) and also events specific to T lineage cells and immune 
function (Fig. 3-7B).  Notably, this analysis revealed described associations in the 
generation of ROS, lymphocyte activation, and lymphocyte proliferation (Fig. 3-7B) in 
the context of potential function of Atg5 in T lineage cells.  Our analyses also revealed a 
connection of Atg5 with cellular processes in which autophagy genes have been shown to 
function, such as phagocytosis, endocytosis, and lysosome formation/function26,34,35 (Fig. 
3-7B).  Finally, we present a diagrammatic summary of the key mitochondrial-associated 
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Atg5-dependent genes in Fig. 3-8, assembled from our literature co-citation analysis, gene 
ontology annotations, network data, and pathway information.  Taken together, these 
transcriptional profiling and computational analyses of orthogonal data, ranging from 
gene co-regulation to protein-protein interaction network with pathway analysis, suggest 
a role for Atg5 in mitochondrial maintenance and function.   
 
Atg5-deficient T cells have a defect in proliferation and increased 
Annexin-V staining  
 Given these transcriptional alterations in Atg5-deficient T cells, we further 
characterized the T cells that develop in the absence of Atg5.  The expression of the 
maturation marker CD24 (HSA) was similar between wild-type and Atg5-deficient T 
cells, indicating that peripheral Atg5-deficient T cells were phenotypically mature.  
Strikingly, however, we observed an alteration in the expression of markers associated 
with activation/memory/homeostatic expansion, CD44 and CD62L (Fig. 3-9A and 3-9B).  
While the majority of wild-type lymph node and splenic T cells were CD62Lhigh CD44low, 
Atg5-deficient T cells were predominantly CD44high and CD62Llow.  Peripheral T cells 
from Atg7flox/flox-Lck-Cre+ mice had a similar expression profile for CD44 and CD62L 
(data not shown).  Increased cell surface expression of CD44 and decreased expression of 
CD62L have been reported in T cells undergoing homeostatic expansion36,37,38,39,40.  
Importantly, expression levels of T cell antigen receptor did not appear altered in the 
Atg5-deficient T cells, nor were there significant differences in the expression of the early 
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activation markers CD25 and CD69 (Fig. 3-9A), consistent with the hypothesis that Atg5-
deficient T cells may be responding to homeostatic rather than antigen-induced expansion 
signals41. 
 T cells in lymphopenic mice undergo multiple rounds of proliferation in order to 
reach peripheral homeostasis42.  The decreased number of peripheral T cells together with 
a surface phenotype indicative of homeostatic expansion suggest that Atg5-deficient T 
cells may be unable to populate the peripheral lymphoid organs, possibly due to survival 
defects, resulting in a compensatory proliferative response.  Consistent with this view, we 
found that a higher percentage of freshly isolated T cells from Atg5-/- chimeras stained 
with Annexin-V compared with T cells from Atg5+/+ chimeras.  The proportion of 
Annexin-V+ cells was 1.5- to 2-fold higher in CD62Llow Atg5-deficient T cells, and 3- to 
7-fold higher in CD62Lhigh Atg5-deficient T cells (Fig. 3-9C).  Annexin-V staining was 
also elevated in CD62Lhigh populations of Atg5flox/flox-Lck-Cre+ T cells (Fig. 3-9D).  
These data suggest that Atg5 is required for the survival of T lymphocytes.   
 Consistent with the results of Pua et al.5, Atg5-deficient T cells exhibited a severe 
defect in TCR-induced proliferation (Fig. 3-10).  We purified CD62Lhigh T lymphocytes 
from control and Atg5-/- chimeras, labeled them with CFSE, stimulated them with anti-
CD3 and anti-CD28 antibodies, and analyzed proliferation at 72 hours.  We also 
measured blast formation using T cells stimulated with anti-CD3 and anti-CD28 
antibodies for 40 hours.  We observed a severe reduction in proliferation and the ability 
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to form blasts in Atg5-deficient T cell cultures compared to controls (Fig. 3-10).  We 
conclude that Atg5 is important for T cell proliferation after antigen receptor stimulation.  
  
Increased mitochondrial mass in Atg5-deficient T lymphocytes 
 Our transcriptional profiling analyses of Atg5-deficient T cells raised the 
possibility that the defects in T cell homeostasis observed in the absence of Atg5 are due 
to impaired mitochondrial function.  To determine if mitochondria were normal in the 
absence of Atg5, we analyzed mitochondrial mass/volume in single cells using the vital 
dye Mitotracker green, a mitochondrial specific dye.  We observed an increase in 
Mitotracker staining in Atg5-deficient splenic CD4+ and CD8+ T cells from both Atg5-/- 
chimeric and Atg5flox/flox-Lck-Cre+ mice relative to controls (Fig. 3-11A and data not 
shown).  The Mitotracker staining of thymocytes from Atg5-/- chimeras was similar to 
wild-type cells, suggesting that the increase in mitochondrial mass occurred as the T cells 
aged (data not shown).   
 We next asked if alterations in mitochondrial mass correlated with the decrease in 
cell survival in Atg5-deficient T cells.  We costained splenocytes from Atg5flox/flox-Lck-
Cre+ and Atg5flox/flox-Lck-Cre- mice with Mitotracker green and Annexin-V.  CD4+ and 
CD8+ T cells that were Mitotrackerhigh had a significantly higher percentage of cells that 
were Annexin-V+ compared with Mitotrackerlow T cells (Fig. 3-11B).  Although this 
trend was apparent in both Atg5flox/flox-Lck-Cre+ and Atg5flox/flox-Lck-Cre- mice, there was 
an increase of approximately 15% in the percentage of Annexin-V+ cells within the 
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Mitotrackerhigh population in Atg5flox/flox-Lck-Cre+ mice (Fig 3-11B).  This data shows 
that mitochondrial mass correlates with Annexin-V staining in CD4+ and CD8+ T cells, 
suggesting that the increase in mitochondrial mass in Atg5-deficient T cells correlates 
with increased death in these cells. 
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Discussion 
 The data presented here indicates that autophagy is an active process during all 
stages of T lymphocyte development and that deletion of the essential autophagy genes 
Atg5 and Atg7 results in profound abnormalities in T cell maintenance.  In addition, we 
showed that Atg5 is important for T cell proliferation in vitro.  Transcriptional profiling 
of Atg5-deficient thymocytes suggests abnormalities in mitochondria in the absence of 
this autophagy gene.  This hypothesis is supported by studies demonstrating that 
peripheral Atg5-deficient T cells have an increase in mitochondrial mass.  Mitochondrial 
mass is correlated with Annexin-V staining in these cells, suggesting a link between 
mitochondrial abnormalities and Atg5-deficient T cell death.  Given our gene chip and 
mitochondrial mass results, we propose that autophagy is required in T lymphocytes for 
normal mitochondrial maintenance.  
 Although dramatic mitochondria-related transcriptional changes were observed in 
thymocytes, we did not observe an increase in mitochondrial mass in Atg5-deficient 
thymocytes, but only in peripheral Atg5-deficient T cells.  Despite the two-fold decrease 
in thymus cellularity in Atg5-/- chimeras, we also did not observe an increase in Annexin-
V staining in the thymus, consistent with previously published results5.  We hypothesize 
that we are unable to detect mitochondrial abnormalities because the cells have not yet 
accumulated sufficient damaged mitochondria to die.  Alternatively, the actively 
phagocytic cells of the thymus responsible for the normal elimination of thymocytes that 
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have failed the selection process43 may be quickly removing those Atg5-deficient 
thymocytes that have accumulated damaged mitochondria.   
 Another group has also recently reported that autophagy genes are important for 
mitochondrial maintenance in T cells47.  Pua et al. studied Atg7-deficient T cells and 
found that, similar to Atg5-deficient cells, these cells have a reduction in peripheral T cell 
numbers with an increase in markers of apoptosis.  Both Atg7 and Atg5-deficient 
peripheral T cells have an increase in mitochondrial mass, which the authors suggest is 
due to an inability of the cells to degrade mitochondria as they mature and leave the 
thymus.  Atg7-deficient cells also have an abnormal accumulation of ROS and 
upregulated expression of Bcl-2 and Bak47.  This report confirms our mitochondrial 
results in Atg5-deficient T cells using Atg7-deficient T cells, suggesting that this 
phenotype is not due to a non-autophagy function of Atg5.  They also extend our findings 
to show that the accumulation of mitochondria is associated with alterations in ROS and 
Bcl-2 family member protein expression, both of which could contribute to increased T 
cell death48,12,13,14,15 (reviewed in 49,50). 
 We utilized three different approaches in this study to address the importance of 
autophagy genes in T lineage cells.  In the first approach, Rag1-/- complementation, 
analysis of Atg5-/- T cells is potentially complicated due to the decrease in viability of 
Atg5-/- chimeras (data not shown) and the deletion of Atg5 in other hematopoietic cell 
types in addition to T cells, resulting in defects in other cell lineages21.  By using a 
conditional knockout approach we ascertained that Atg5 is required within T cells for 
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their maintenance in vivo.  Our immunoblot results suggest that deletion of the Atg5flox 
alleles may be incomplete in some cells or that the ATG5 protein may be retained for a 
significant time after gene deletion.  Despite these caveats, given that the in vivo 
phenotypes of Atg5-/-, Atg5flox/flox-Lck-Cre+, and Atg7flox/flox-Lck-Cre+ T cells are similar, 
it is likely that these phenotypes are due to the lack of autophagy in T cells, and not due 
to non-autophagy functions of Atg525 or Atg7.  However, since ATG7 is essential for the 
conjugation of ATG5 to ATG1245,46, it is possible that a non-autophagy role of the 
ATG5-12 conjugate is responsible.  Further studies would be necessary to distinguish 
between these possibilities.   
 It is interesting that the transcriptional signature observed here for Atg5-deficient 
thymocytes is quite distinct from the signature observed in Paneth cells that express 
lower than normal levels of ATG16L144.  This suggests that the transcriptional response 
to autophagy gene-deficiency may differ depending on the primary cell type involved or 
the specific gene affected.  These differences may help to explain the different functions 
of autophagy genes in closely related cell lineages21. 
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Table 3-1.  Loss of T cells in Atg5-/-, Atg5flox/flox-Lck-Cre+, and Atg7flox/flox-
Lck-Cre+ mice 
Data are mean ± SEM and represent multiples of 106 cells.  The number of mice per 
group is indicated in parentheses.  Chimera mice were analyzed between 6 and 13 weeks 
post-reconstitution.  Atg5flox/flox-Lck-Cre+ and Atg5flox/flox-Lck-Cre- mice were analyzed 
between 6 and 13 weeks of age.  Atg7flox/flox-Lck-Cre+ and Atg7flox/flox-Lck-Cre- mice 
were analyzed between 8 and 14 weeks of age. 
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Figure 3-1.  Constitutive autophagy in all subsets of wild-type T cells  
(A) Lysates from FACS-sorted C57BL/6 thymocytes and MACS-bead sorted peripheral 
T cells were probed with antibodies against LC3 and β-actin.  Representative blot from 4 
independent experiments shown.  (B) Lysates from C57BL/6 thymocytes cultured for 4 
hours with the indicated concentrations of chloroquine were probed with antibodies 
against LC3 and β-actin.  Representative blot from 3 independent experiments shown. 
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Figure 3-2.  Deletion of ATG5 in Atg5-/- and Atg5flox/flox-Lck-Cre+ 
thymocytes and ATG7 in Atg7flox/flox-Lck-Cre+ thymocytes 
(A) Lysates from Atg5+/+ or Atg5-/- chimeras or C57BL/6 control thymocytes were 
probed with antibodies against ATG5, LC3, or β-actin.  Representative blot from 2 
independent experiments shown.  (B) Lysates from Atg5+/+ and Atg5-/- SV40-transformed 
murine embryonic fibroblasts and from Atg5flox/flox-Lck-Cre+ and Atg5flox/flox-Lck-Cre- 
thymocytes were probed with antibodies against ATG5 and β-actin.  Representative blot 
from 3 independent experiments shown.  (C) Lysates from Atg7flox/flox-Lck-Cre+ and 
Atg7flox/flox-Lck-Cre- thymocytes were probed with antibodies against ATG7 and β-actin.  
Representative blot from 2 independent experiments shown.   
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Figure 3-3.  Loss of T cells in Atg5-/-,  Atg5flox/flox-Lck-Cre+, and 
Atg7flox/flox-Lck-Cre+ mice 
Single-cell suspensions of thymocytes, splenocytes, and lymph node cells were analyzed 
by flow cytometry as described in Materials and Methods.  Cells were gated by forward 
and side scatter on lymphocyte populations.  Shown is one representative experiment 
from n ≥ 3 experiments, with at least 7 mice of each genotype analyzed. 
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Figure 3-4.  Atg5 is required for the proper 
regulation of 699 genes in thymocytes 
Microarray analysis showing genes differentially 
expressed (p<0.05), of which 259 genes were induced and 
440 down-regulated in Atg5-/- thymocytes compared to 
wild-type thymocytes.  Expression values for each 
probeset were z-score-transformed across all arrays and 
their intensities above and below the mean are represented 
on the heatmap by red and green colors respectively, as 
shown on the color bar.  Genes were hierarchically 
clustered using Cluster 3.0 and visualized with Java 
TreeView.  
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Figure 3-5.  Atg5 is required for the proper regulation of mitochondrial-
associated genes 
(A) Differentially expressed genes were classified into gene ontology (GO) cellular 
component categories. Categories assigned with at least 3 genes are displayed in the pie 
A
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chart, with enrichment p-values shown in 
brackets alongside each category.  The bar 
chart displays enrichment p-values as 
negative log-transformed values, which 
reveals a dramatic enrichment of 
mitochondria- and the nucleus-associated 
genes.  (B) 64 differentially expressed genes 
that fall into the mitochondrion GO category 
are displayed by heatmap, prepared as 
described in Fig 3-4.  
B
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Figure 3-6.  Construction of a human protein-protein interaction 
network 
Differentially expressed genes were mapped onto human orthologs for which interaction 
data was available. Circles representing up-regulated components are colored red and 
down-regulated components green. Solid lines denote protein-protein interactions. 
Mitochondrion-anchored subnetworks (highlighted by the grey region) emerged when 
extending connections by an additional degree of separation, capturing components of 
interest (blue circles) in the functional neighborhood of mitochondrial-related genes that 
were found to be differentially expressed.  Network clusters containing connections 
between at least 3 components are displayed. 
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 Figure 3-7.  Matrices generated from 
literature co-citation analysis of 
differentially expressed genes and citation 
terms associated with mitochondrial and 
cellular functions 
(A) Mitochondrial functions and (B) general cellular 
processes or specific T-lineage immune functions 
displayed as a heatmap.  The intensity of red on the 
heatmap denotes the extent to which each gene is 
co-cited with each specific term in the PubMed 
database. 
A
B
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Figure 3-8.  Diagrammatic mitochondrion representation showing 
important differentially-expressed gene products participating in 
mitochondria-associated processes 
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Red and green ovals denote up- and down-regulated components in Atg5-/- thymocytes, 
respectively.  Functional associations with biological processes are represented by dashed 
lines. 
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Figure 3-9.  A higher percentage of T cells are CD44high, CD62Llow, and 
Annexin-V+ in Atg5-/- chimeras and Atg5flox/flox-Lck-Cre+ mice compared 
with controls  
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(A-B) Flow cytometric analysis of lymph node T cells from Atg5+/+ or Atg5-/- chimeric 
mice (A) or Atg5flox/flox-Lck-Cre- and Atg5flox/flox-Lck-Cre+ mice (B).  Cells were gated by 
forward and side scatter for lymphocytes, then gated on CD4+ or CD8+ cells.  One 
representative experiment shown of at least five independent experiments.  (C-D) Lymph 
node T cells from Atg5+/+ or Atg5-/- chimeric mice (C) or Atg5flox/flox-Lck-Cre- and 
Atg5flox/flox-Lck-Cre+ mice (D) were stained with Annexin-V and antibodies against CD4, 
CD8, and CD62L.  Cells were gated by forward and side scatter for lymphocytes, then 
gated on CD4+ or CD8+ cells.  Data pooled from at least four independent experiments.  
(* p < 0.05, ** p < 0.005, *** p < 0.0005, n.s. = not statistically significant) 
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Figure 3-10.  Atg5-deficient T lymphocytes have a defect in proliferation 
Purified CD62Lhigh T cells from Atg5+/+ or Atg5-/- chimeric mice were either untreated or 
stimulated with anti-CD3 (1μg/mL) and anti-CD28 (1μg/mL) and analyzed 40 hours later 
for T cell blasts (left panels) or loaded with CFSE, stimulated as above, and analyzed 72 
hours later (right panel).  Shown is one representative experiment of three. 
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Figure 3-11.  Atg5-deficient T lymphocytes have an increase in 
mitochondrial mass 
(A) Splenocytes from Atg5flox/flox-Lck-Cre- and Atg5flox/flox-Lck-Cre+ mice were loaded 
with MitoTracker green, stained with antibodies against CD4 or CD8, and analyzed by 
flow cytometry.  Analysis was performed on CD4+ or CD8+ splenocytes without gating 
by forward and side scatter.  Shown are representative FACS plots of at least fifteen mice 
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of each genotype and the quantification of the mean fluorescence intensity (MFI) of 
Mitotracker staining from one of three independent experiments.  (B) Splenocytes from 
Atg5flox/flox-Lck-Cre- and Atg5flox/flox-Lck-Cre+ mice were stained with CD4, CD8, 
Mitotracker green, and Annexin-V.  Representative FACS plots and quantification of the 
percentage of Annexin-V+ cells from the Mitotrackerhigh and Mitotrackerlow gates are 
shown.  Analysis was performed on CD4+ or CD8+ splenocytes without gating by 
forward and side scatter.  Data pooled from three independent experiments.  (* p < 0.05, 
** p < 0.005, *** p < 0.0005, n.s. = not statistically significant) 
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Materials and Methods 
Mice and cells  The generation of Atg5-/-, Atg5flox/flox, and Atg7flox/flox mice has been 
previously described24,23,28.  Chimeric mice were generated by reconstituting sublethally 
irradiated B6.129S7‑Rag1tm1Mom/J (Rag1-/-, The Jackson Laboratory, #002216) mice with 
Atg5+/+ or Atg5-/- fetal liver cells, as previously described21.  Atg5flox/flox and Atg7flox/flox 
were bred to Lck-Cre (C57BL/6NTac-TgN(Lck-Cre)) transgenic mice (Taconic, 
#004197, Hudson, NY).  Mice were maintained at Washington University School of 
Medicine in accordance with institutional policies for animal care and usage.  Atg5-/- and 
Atg5+/+ embryonic fibroblasts were generated from day 13.5 embryos.  To establish 
immortalized cell lines, 106 cells were transformed with 1µg of pEF321-T, an SV40 large 
T antigen expression vector (a gift from T. Hansen), by the FuGENE HD transfection 
reagent (Roche, Basel, Switzerland) according to the manufacturer’s instructions. 
 
Genotyping  Genotyping of the mice was performed as described24,28, with the Cre 
gene detected with primers cre1 (AGGTTCGTTCACTCATGGA) and cre2 
(TCGACCAGTTTAGTTACCC) using PCR [94°C(4 min); 25 cycles of 94°C (30 sec), 
60°C (30 sec), 72°C (1 min); 72°C (5 min)].  The Atg5 gene was detected with the 
primers exon3‑1 (GAATATGAAGGCACACCCCTGAAATG), short2 
(GTACTGCATAATGGTTTAACTCTTGC), and check2 (ACAACGTCGAGCA 
CAGCTGCGCAAGG) using PCR [94°C (4 min); 30 cycles of 94°C (30 sec), 60°C (30 
sec), 72°C (1 min); 72°C (5 min)].  The same PCR program was used with the primers 
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short2, check2, and 5L2 (CAGGGAATGGTGTCTCCCAC) to check for the Atg5flox and 
deleted Atg5flox alleles in thymocytes from Atg5flox/flox Lck-Cre+ and Atg5flox/flox Lck-Cre- 
mice.  The Atg7flox allele was detected with primers Hind-Fw 
(TGGCTGCTACTTCTGCAATGATGT) and Pst-Rv 
(CAGGACAGAGACCATCAGCTCCAC) using PCR [94°C (5min); 30 cycles of 94°C 
(20 sec), 68°C (30 sec), 72°C (90 sec); 72°C (10 min)].  Confirmation of the wild type 
Atg7 locus was done with primers Ex14 F (TCTCCCAAGACAAGACAGGGTGAA) 
and Ex14 R (AAGCCAAAGGAAACCAAGGGAGTG) using PCR [94°C (5min); 35 
cycles of 94°C (20 sec), 60°C (15 sec), 72°C (60 sec); 72°C (10 min)]. 
 
Stimulation and proliferation assays  Single cell suspensions from the spleens 
and lymph nodes of chimeric mice were first B cell depleted using negative selection 
with anti-B220-Dynal beads (Invitrogen, Carlsbad, CA), followed by positive selection 
for CD62Lhigh lymphocytes.  Briefly, cells were incubated with biotin-conjugated anti-
CD62L antibody (Caltag, Carlsbad, CA) followed by anti-biotin MACs beads (Miltenyi 
Biotec, Auburn, CA) and isolated according to the manufacturer’s instructions.  
CD62Lhigh purities were greater than 90%.  Lymph node T cells were plated at 1x106/mL 
in complete media (DMEM (Gibco, Carlsbad, CA) plus 10% fetal calf serum (FCS), 
100Units/mL penicillin, 100ug/mL streptomycin, 1mM sodium pyruvate, 2mM L-
glutamine, 1x non-essential amino acids (Gibco, Carlsbad, CA) and 57uM β-
mercaptoethanol).  Cells were stimulated with 1.0 μg/mL anti-CD3 and 1.0 μg/mL anti-
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CD28 (BD Biosciences, San Jose, CA).  To label cells with CFSE, cells were incubated 
with 1μM CFSE (Invitrogen, Carlsbad, CA) for 30 minutes at 37° and then washed in 
complete media.  Labeled cells were cultured with the indicated stimuli for 72 hours and 
then analyzed by flow cytometry. 
 
Flow cytometry and cell sorting  Single cell suspensions were prepared from the 
spleens, thymi, and lymph nodes and stained with antibodies against TCRβ, CD4, CD8, 
CD24, CD25, CD44, CD62L, and CD69 (BD Biosciences, San Jose, CA).  Annexin-V 
labeling was performed by surface staining cells with the indicated lineage markers, 
washing with complete media, and staining for 15 minutes with Annexin-V (BD 
Biosciences, San Jose, CA).  Thymocytes were sorted on a FACS Vantage SE (BD 
Biosciences, San Jose, CA) by FSC/SSC gating on a live lymphocyte population, 
followed by gating out CD11b+, CD11c+, and B220+ cells.  The remaining cells were 
then sorted based on expression of CD4 and CD8.  Purities were greater than 94% for 
each population (n = 4 independent experiments).  Peripheral CD4+ and CD8+ T cells 
were isolated using negative selection by MACS magnetic bead sorting according to the 
manufacturer’s instructions (Miltenyi Biotec, Auburn, CA).  Peripheral T cells were 
negatively selected from pooled spleen and lymph node samples, followed by negative 
selection against either CD4+ or CD8+ cells.  Purities averaged 86% for CD4+ cells and 
92% for CD8+ cells (n = 4 independent experiments). 
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Immunoblots  Cells were washed with PBS and then lysed in cold NP-40 lysis buffer 
[0.5% NP-40, 50 mM Tris-Cl, 150 mM NaCl, 1mM EDTA, 1 mM phenylmethylsulfonyl 
fluoride] or cold lysis buffer B [50mM Tris-HCl pH8.0, 150mM NaCl, 1% Triton X-100, 
0.1% SDS, 0.2% deoxycholic acid sodium salt] supplemented with complete pretease 
inhibitors (Roche, Basel, Switzerland) for 10 minutes at 4°C.  Lysates were cleared by 
centrifugation at 14,000 x g for 10 minutes at 4°C.   Samples were analyzed by 
immunoblotting21 using antibodies against ATG5 (Novus Biologicals, Littleton, CO and 
Nanotools, Teningen, Germany), ATG7 (Sigma, St. Louis, MO), LC3 (Novus 
Biologicals, Littleton, CO) and β-actin (Sigma, St. Louis, MO). 
 
Microarrays and analysis  Total thymocyte RNA was harvested from Atg5-/- and 
Atg5+/+ chimeras by lysing single cell suspensions of thymocytes in Trizol (Invitrogen, 
Carlsbad, CA).  RNA analyses were performed at the microarray core facility at the 
Harvard Medical School and Partners Healthcare Center for Genetics and Genomics. The 
quantity, purity and integrity of RNA were evaluated by UV spectrophotometry and 
RNA-nano Bioanalyzer (Agilent, Santa Clara, CA). Sample processing and hybridization 
on Mouse Genome 430 2.0 GeneChip microarrays (Affymetrix, Santa Clara, CA) were 
performed according to manufacturer’s instructions. Probe-level normalization of the raw 
.CEL data files using the GC Robust Multi-array Average (GCRMA) algorithm51 was 
implemented in the R programming language. Two-sided t-tests were performed for each 
probeset, comparing between Atg5-/- and Atg5+/+ chimera samples. Probesets with p<0.05 
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were considered differentially expressed.  Hierarchical clustering (pairwise complete-
linkage) of probesets corresponding to differentially expressed genes was performed with 
Cluster 3.052 using the Pearson’s correlation coefficient as the similarity metric. Z-score 
transformation was applied to each probeset across all arrays prior to generating 
‘heatmaps’ for visualization implemented in the Python language.  
 
Gene Ontology (GO) analysis  Differentially expressed genes were examined in 
terms of GO cellular component categories29.  To assess enrichment of these categories 
within the set of differentially expressed genes against all genes represented by probes on 
the Affymetrix Mouse Genome 430 2.0 microarray GeneChip, p-values were computed 
using Fisher’s exact test implemented in Python and R programming languages. 
Categories with p<0.05 were considered significantly enriched.  
 
Protein interaction network  The network was constructed by iteratively 
connecting interacting proteins, with data extracted from a collection of genome-wide 
interactome screens and curated literature entries in HPRD30.  The network uses graph 
theoretic representations, which abstract components (gene products) as nodes and 
relationships (e.g. interactions) between components as edges, implemented in the Perl 
programming language.  
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Literature co-citation analysis  Co-citation analysis was performed using Milano 
search32, identifying the number of times a gene was co-cited with a specified term in 
articles from the PubMed database. Vectors capturing the co-citation profiles for each of 
these genes were generated for a set of terms and clustered using pairwise complete-
linkage hierarchical clustering with the Pearson’s correlation coefficient as the similarity 
measure.  The results were displayed as a heatmap implemented in the Python language. 
 
Mitochondria mass/volume assay  Cells were loaded with 100nM MitoTracker 
Green (Invitrogen, Carlsbad, CA) for 30 minutes at 37°C in the presence of flourochome-
conjugated antibodies against CD4 and CD8.  Cells were washed and then analyzed by 
flow cytometry.  When necessary, Annexin-V was added after washing the cells in 
complete media. 
 
Statistics  All non-gene chip data was analyzed with Prism software (Graphpad; San 
Diego, CA), using two-tailed unpaired Student’s t tests. 
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CHAPTER 4 
The LC3 Conjugation System is Important for Directional 
Secretion in Osteoclasts 
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Abstract 
 Osteoclasts function to degrade bone by regulated secretion of lysosomal enzymes 
and acid against the bone surface.  The mechanisms regulating this secretion are poorly 
understood.  Here we show that the biochemical pathway necessary for autophagy is 
critical for secretion in osteoclasts.  We found that LC3 localizes to the ruffled border in 
osteoclasts.  We hypothesized that this localization may be important for osteoclast 
function, so we inhibited the LC3 conjugation cascade by deleting the essential 
autophagy genes Atg5 or Atg7 or overexpressing a dominant negative mutant of ATG4B.  
All of these disruptions inhibited bone resorption and localization of lysosomal markers 
to the resorptive surface in vitro.  Expression of dominant negative ATG4B also 
decreased localization of LC3 to the ruffled border, suggesting that LC3 localization and 
osteoclast function are connected.  Finally, deletion of Atg5 in osteoclasts and other 
myeloid-lineage cells in vivo protected mice from ovariectomy-induced bone loss, a 
mouse model of osteoporosis.  Our results demonstrate that the LC3 conjugation pathway 
is important for directional secretion in osteoclasts. 
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Introduction 
 Osteoclasts are multinucleated cells of the monocyte lineage that degrade bone by 
directionally secreting lysosomal enzymes and hydrogen ions against the bone surface 
(Fig. 1-2, reviewed in 1).  This secretion is targeted through undefined mechanisms to an 
area of the plasma membrane juxtaposed to the bone and circumscribed by an actin ring, 
forming a “ruffled border” of convoluted membrane.   The goal of this chapter is to 
determine if autophagy or autophagy genes are important for osteoclast function. 
 Many of the proteins involved in autophagosome nucleation also regulate vesicle 
trafficking.  There is a growing literature suggesting that autophagy genes downstream of 
nucleation are important for secretory cell function2,3,4,5.  In addition, LC3 localizes to the 
phagosome during phagocytosis and enhances fusion of phagosomes to lysosomes6, 
suggesting that the LC3 conjugation system may be involved in vesicular trafficking 
pathways independent of classical autophagosome formation.   
 In this chapter we report that LC3 is found concentrated at the ruffled border in 
osteoclasts, but this localization is reduced in osteoclasts expressing a dominant negative 
mutant of ATG4B, ATG4BC74A.  Deletion of Atg5 or Atg7 or overexpression of 
ATG4BC74A or a mutant of ATG5, ATG5K130R, all inhibit osteoclast function in vitro, as 
measured by bone pit formation and localization of lysosomal proteins to the ruffled 
border.  Deletion of Atg5 in myeloid-lineage cells in vivo protects mice from bone loss 
induced by ovariectomy.  We demonstrate an important role for the LC3 conjugation 
machinery in osteoclast secretion. 
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Results 
GFP-LC3 localizes to the ruffled border 
 As a first step to understand the role of autophagy and LC3 conjugation in 
osteoclasts, we visualized LC3 localization in osteoclasts using GFP-tagged LC3 (GFP-
LC3)7.  LC3 is normally found on the developing autophagosome where it promotes 
membrane elongation8,9,10,11,12.  We cultured osteoclasts from GFP-LC3 transgenic mice13 
by growing bone marrow-derived macrophages in the presence of M-CSF-containing 
conditioned media for 4 days and then replating equal cell numbers on bone in the 
presence of M-CSF and RANKL, a cytokine necessary for osteoclastogenesis14.  We 
stained the cells to visualize actin and GFP-LC3 and identified active osteoclasts as 
multinucleated cells with an actin ring.  Confocal microscopy showed LC3 not only in 
punctate cytoplasmic structures, which we presume to be autophagosomes, but also 
concentrated within the actin ring in approximately 25% of osteoclasts (Fig. 4-1).  We 
also stained the cells with an antibody against cathepsin K, a lysosomal protease that is 
secreted from the cells and localizes to the ruffled border15.  GFP-LC3 was found in the 
same region of the cell as cathepsin K, demonstrating that GFP-LC3 localizes to the 
resorptive microenvironment.  Interestingly, we did not observe colocalization of GFP-
LC3 and cathepsin K puncta in the cell periphery, suggesting that LC3 does not localize 
to cathepsin K+ vesicles.  Based on these results, we sought to determine the functional 
significance of the presence of LC3 in the actin ring. 
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Atg5 is not required for osteoclast differentiation but is important for 
osteoclast secretion 
 ATG5 is an essential autophagy protein required for the conjugation and 
localization of LC3 to autophagosomes and phagosomes16,6.  To delete Atg5 in 
osteoclasts, we bred mice containing two copies of a knock-in Atg5 gene in which LoxP 
sites were inserted flanking the third exon [Atg5flox/flox]17 to mice expressing the Cre 
recombinase under control of the LyzM promoter, resulting in expression of the 
recombinase in cells of the myeloid lineage17,18,19.  Given the function of Atg5 in B and T 
cell development (see Chapters 2 and 3), we first determined if osteoclasts can be 
differentiated from Atg5flox/flox-LyzM-Cre+ bone marrow.  We counted osteoclasts grown 
on plastic on days 3, 4, and 5 post addition of RANKL.  Osteoclasts were identified as 
cells with at least 3 nuclei that stained for the osteoclast marker tartrate-resistant acid 
phosphatase (TRAP)20,21,22.  Atg5flox/flox-LyzM-Cre+ cells had a delay in osteoclast 
formation, but by day 5 we observed equal numbers of mature osteoclasts in Atg5flox/flox-
LyzM-Cre+ and Atg5flox/flox-LyzM-Cre- cultures (Fig. 4-2).  To explore this difference, 
we performed immunoblots against cathepsin K and c-Src, two proteins that are 
upregulated during osteoclastogenesis23,20,24.  Immunoblot analysis revealed similar 
kinetics of upregulation of both cathepsin K and c-Src, indicating that this aspect of 
differentiation of macrophages into osteoclasts is not impaired in Atg5flox/flox-LyzM-Cre+ 
cells (Fig. 4-3A).   
 To further assess osteoclast formation in the absence of Atg5, we grew cells from 
Atg5flox/flox-LyzM-Cre+ and Atg5flox/flox-LyzM-Cre- mice on bovine cortical bone 
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fragments and counted the number of nuclei per osteoclast on day 6.  We observed no 
difference in the average number of nuclei per cell between Atg5flox/flox-LyzM-Cre+ and 
Atg5flox/flox-LyzM-Cre- osteoclasts (Fig. 4-3B).  We also stained for actin and confirmed 
that nearly 100% of both Atg5flox/flox-LyzM-Cre+ and Atg5flox/flox-LyzM-Cre- osteoclasts 
form actin rings, a hallmark of active osteoclasts grown on bone substrate (data not 
shown).  Finally, to ensure that osteoclasts from Atg5flox/flox-LyzM-Cre+ mice had deleted 
Atg5 and that non-recombined cells were not growing out in culture, we analyzed ATG5 
protein expression in osteoclasts grown for 6 days in vitro.  We observed a dramatic 
reduction in ATG5 protein levels, inhibition of LC3 conjugation, and accumulation of 
p62, consistent with an inhibition of autophagy in these cells (Fig. 4-4)25.  From these 
results we conclude that Atg5 is not required for osteoclast formation. 
 We next determined whether Atg5-deficient osteoclasts were functionally 
competent by analyzing their ability to degrade bone in vitro.  We cultured Atg5flox/flox-
LyzM-Cre+ and Atg5flox/flox-LyzM-Cre- osteoclasts on bone for 6 days, removed the 
osteoclasts from the bone fragments and stained the bones with FITC-conjugated wheat 
germ agglutinin, a lectin that binds to the organic matrix of bone exposed by 
degradation26.  This technique allowed us to measure the depth of bone pits generated by 
the cells using confocal microscopy.  Bone resorption pits formed by Atg5flox/flox-LyzM-
Cre- control osteoclasts were approximately twofold deeper than pits formed by 
Atg5flox/flox-LyzM-Cre+ osteoclasts (Fig. 4-5).  This data suggests that Atg5 is required for 
normal bone resorption by osteoclasts in vitro. 
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 Osteoclast bone degradation requires regulated, directional secretion of lysosomal 
enzymes against the bone surface (reviewed in 27).  To determine if this process was 
normal in Atg5flox/flox-LyzM-Cre+ osteoclasts, we examined the intracellular localization 
of cathepsin K, a lysosomal protease important for bone degradation, and LAMP1, a 
lysosomal transmembrane protein.  Secretion of lysosomes by active osteoclasts localizes 
both of these markers to the ruffled border, with LAMP1 localized on the plasma 
membrane28,15.  We observed a significant reduction in the percentage of Atg5flox/flox-
LyzM-Cre+ osteoclasts with cathepsin K localized in the actin ring compared with 
Atg5flox/flox-LyzM-Cre- osteoclasts (Fig. 4-6; Atg5flox/flox-LyzM-Cre-: 53.1 ± 2.4%; 
Atg5flox/flox-LyzM-Cre+: 24.3 ± 3.2%; p = 0.002).  Similarly, LAMP1 localization was 
also reduced in Atg5flox/flox-LyzM-Cre+ osteoclasts (Fig. 4-6; Atg5flox/flox-LyzM-Cre-: 59.0 
± 1.4%; Atg5flox/flox-LyzM-Cre+: 23.7 ± 3.7%; p = 0.0009).   
 Cathepsin K is synthesized as a pro-enzyme that must be cleaved in the lysosome 
to be active29.  To confirm that we were measuring lysosome secretion in our 
immunofluorescence assays and not abnormal cathepsin K expression in Atg5flox/flox-
LyzM-Cre+ osteoclasts, we measured levels of pro-form and active cathepsin K.  
Immunoblotting of lysates from plastic-grown osteoclasts 6 days after addition of 
RANKL revealed no difference in the levels of the pro-form or processed, active form of 
cathepsin K (Fig. 4-7), arguing that delivery of cathepsin K to lysosomes is intact in the 
absence of Atg5.  Together, this data suggests that secretion of lysosomes at the ruffled 
border is impaired in the absence of Atg5.   
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Conjugation of ATG5 to ATG12 is important for osteoclast function 
         To assess if this phenotype may be due to a non-autophagy function of Atg5, we 
deleted Atg7, another essential autophagy gene, in osteoclasts.  ATG7 is an E1-like 
enzyme that is required for conjugation of ATG5 to ATG1230.  We bred Atg7flox/flox mice 
to LyzM-Cre mice to generate Atg7flox/flox-LyzM-Cre+ mice31.  Immunoblotting of 
osteoclasts grown from these mice revealed that these cells had a significant reduction in 
ATG7 protein levels and partial inhibition of LC3-I to LC3-II conversion (Fig. 4-8).  
There was no delay in the formation of Atg7flox/flox-LyzM-Cre+ osteoclasts (data not 
shown).  Similar to our findings with Atg5-deficient osteoclasts, we observed a decrease 
in the depth of bone pits generated by Atg7-deficient osteoclasts (Fig. 4-9a).  Atg7flox/flox-
LyzM-Cre+ osteoclasts also had a significant reduction in cathepsin K localization (Fig. 
4-9B; Atg7flox/flox-LyzM-Cre-: 58.6 ± 2.1%; Atg7flox/flox-LyzM-Cre+: 30.2 ± 3.1%; p = 
0.017) and LAMP1 localization (Fig. 4-9B; Atg7flox/flox-LyzM-Cre-: 58.6 ± 2.1%; 
Atg7flox/flox-LyzM-Cre+: 37.8 ± 0.8%; p = 0.0116).  These data demonstrate that a second 
essential autophagy gene is important for osteoclast function.  Given the requirement of 
ATG7 for the conjugation of ATG5 and the concordance of the phenotypes of Atg5- and 
Atg7-deficient osteoclasts, we hypothesize that the ATG5-ATG12 conjugate is involved 
in osteoclast secretion. 
To test our hypothesis, we generated retroviruses expressing either mCherry-
ATG5WT or mCherry-ATG5K130R, a mutant of ATG5 in which the lysine required for 
conjugation to ATG12 has been changed to an arginine32,16,33.  Immunoblotting of 
transduced osteoclasts demonstrated expression of the wild-type and mutant mCherry-
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ATG5 fusion proteins at higher levels than endogenous ATG5.  We confirmed that 
mCherry-ATG5K130R does not form the higher molecular weight band of the expected 
size for the mCherry-ATG5-ATG12 conjugate, consistent with the published phenotype 
of this mutant (Fig. 4-10)32.  Expression of mCherry-ATG5WT, but not mCherry-
ATG5K130R, restored the synthesis of LC3-II in Atg5flox/flox-LyzM-Cre+ osteoclasts.  
Interestingly, expression of the ATG5K130R mutant, but not the wild-type protein, in 
Atg5flox/flox-LyzM-Cre- osteoclasts reduced LC3-II levels, suggesting that this mutant 
might function as a dominant negative in the LC3 conjugation pathway in our system. 
We measured bone pit depth and cathepsin K localization in ATG5-transduced 
Atg5flox/flox-LyzM-Cre+ and Atg5flox/flox-LyzM-Cre- osteoclasts.  Expression of mCherry-
ATG5WT in Atg5flox/flox-LyzM-Cre+ osteoclasts restored bone pit depth to control levels, 
whereas mCherry-ATG5K130R did not increase bone pit depth (Fig. 4-11A).  Similarly, 
expression of wild-type ATG5, but not ATG5K130R, increased cathepsin K localization in 
Atg5flox/flox-LyzM-Cre+ osteclasts to levels comparable to Atg5flox/flox-LyzM-Cre- controls 
(Fig. 4-11B).  Interestingly, Atg5flox/flox-LyzM-Cre- osteoclasts expressing mCherry-
ATG5K130R had decreased bone pit formation and cathepsin K localization, consistent 
with our observation that ATG5K130R inhibits the function of endogenous ATG533,9,34.  
Based on these results and our studies in Atg7-deficient osteoclasts, we conclude that the 
ATG5-ATG12 conjugate is important for osteoclast secretion. 
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Inhibiting the LC3 conjugation pathway decreases osteoclast secretion 
 The ATG5-ATG12 conjugate is important for LC3 conjugation, but it may have 
additional functions in the cell35.  To determine if LC3 conjugation is required for 
osteoclast function, we next inhibited the LC3 conjugation pathway without affecting the 
conjugation of ATG5 to ATG12.  ATG4B is a cysteine protease required for processing 
of the pro-form of LC3 and deconjugation of LC3 from phosphatidylethanolamine (PE) 
36.  Mutating the catalytic cysteine residue generates a dominant negative enzyme 
(ATG4BC74A) that sequesters LC3 and inhibits its conjugation to PE, inhibiting autophagy 
without disrupting formation of the ATG5-ATG12 conjugate37.  We retrovirally 
expressed ATG4BC74A fused to mStrawberry in wild-type osteoclasts.  As a control, we 
used either GFP or vector-only retroviruses.  Immunoblotting revealed expression of the 
ATG4BC74A fusion protein (Fig. 4-12).  We measured bone pit formation and cathepsin K 
localization and found that ATG4BC74A-expressing osteoclasts had reduced bone pit 
depth and cathepsin K localization in the actin ring compared with control transduced 
cells (Fig. 4-13A and 4-13B).  Expression of ATG4BC74A in GFP-LC3 osteoclasts also 
inhibited localization of GFP-LC3 to the actin ring (Fig. 4-14).  This data demonstrates 
that the LC3 conjugation pathway is required for osteoclast function and suggests that 
LC3 conjugation is an important process in osteoclast secretion.  Since inhibition of GFP-
LC3 localization correlates with decreased vesicular secretion, one explanation is that 
osteoclast function requires the proper targeting of LC3 to the actin ring through its 
conjugation by the autophagy machinery. 
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Atg5flox/flox-LyzM-Cre+ mice are protected from ovariectomy-induced 
bone loss 
 Estrogen-deficiency osteoporosis is a common disease of the elderly associated 
with significant morbidity and mortality (reviewed in 38).  This condition can be induced 
in female lab animals by ovariectomy39.  To determine if the Atg5 is important for 
regulating skeletal mass in vivo, we induced osteoclast activity by removing the ovaries 
from female Atg5flox/flox-LyzM-Cre+ and Atg5flox/flox-LyzM-Cre- mice.  We measured bone 
mass in 8-week old Atg5flox/flox-LyzM-Cre+ and Atg5flox/flox-LyzM-Cre- mice by 
microcomputed tomography (μCT) before and after ovariectomy or a sham operation.  At 
baseline, we observed a small increase in trabecular bone volume (BV/TV) in Atg5flox/flox-
LyzM-Cre+ mice (Fig. 4-15A).  One month after the sham operation we observed no 
difference in the percentage of bone lost between Atg5flox/flox-LyzM-Cre+ and Atg5flox/flox-
LyzM-Cre- sham-treated animals.  However, Atg5flox/flox-LyzM-Cre+ mice had a 55% 
reduction (p = 0.0393) in ovariectomy-induced bone loss compared with Atg5flox/flox-
LyzM-Cre- controls (Fig. 4-15B).  This data is consistent with the hypothesis that 
Atg5flox/flox-LyzM-Cre+ mice have dysfunctional osteoclasts, suggesting that our in vitro 
phenotype is relevant in vivo.  In addition, the function of Atg5 in osteoclasts may be 
important for the pathophysiology of osteoporosis. 
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Discussion 
 Here we show that GFP-LC3 localizes to the actin ring in activated osteoclasts.  
Deletion of two essential autophagy genes (Atg5, Atg7) in the autophagy pathway or 
retroviral expression of a dominant negative ATG4BC74A or ATG5K130R inhibit osteoclast 
function as measured by bone pit depth and cathepsin K localization.  We confirmed that 
the secretion defect in Atg5flox/flox-LyzM-Cre+ osteoclasts is due to deletion of ATG5 in 
these cells by rescuing this phenotype with retroviral expression of wild-type ATG5.  
Together, these studies demonstrate that the biochemical pathway required for LC3 
conjugation and autophagosome formation is critical for osteoclast secretion.  Finally, 
mice lacking Atg5 in osteoclasts and other myeloid-lineage cells are protected from 
ovariectomy-induced bone loss.  
 Given these findings connecting proteins involved in a cellular degradation 
pathway and osteoclast secretion, it is useful to compare our results with published 
phenotypes of osteoclasts deficient in proteins known to be important for bone 
degradation, osteoclast activation, and secretion.  We found a 55% reduction in bone pit 
depth generated by Atg5-deficient osteoclasts, which is comparable with the reduction in 
pit depth by cathepsin K knockout osteoclasts (44% reduction) and β3 integrin knockout 
osteoclasts (38% reduction)40,41.  We observed a twofold reduction in cathepsin K 
localization in the actin ring, similar to the 3-fold reduction reported in osteoclasts 
lacking Synaptotagmin VII, an important regulator of lysosome exocytosis42,43.  Finally, 
our results demonstrating a 55% reduction in ovariectomy-induced bone loss are 
comparable with protection offered by bisphosphonate treatment of ovariectomized rats 
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(74% reduction) or cathepsin K inhibitor treatment of ovariectomized mice (73% 
reduction)44,45.  This comparison demonstrates the importance of autophagy genes in 
osteoclast biology and suggests that the biochemical pathway necessary for autophagy 
may be a new target to treat bone disease. 
 The observation that 8-week old Atg5flox/flox-LyzM-Cre+ mice have a minimal 
increase in basal bone mass but are protected from ovariectomy-induced bone loss 
suggests that ATG5 is important for osteoclast function after activation in vivo.  Our in 
vitro results demonstrate that Atg5-deficient osteoclasts can be activated, as demonstrated 
by normal formation of actin rings, but have reduced secretion after activation.  
Interestingly, β3 integrin-deficient mice are also protected from ovariectomy-induced 
bone loss, do not have a basal difference in bone density when young (<4 months), but 
develop severe osteosclerosis by six months of age41,46.  It will be interesting to determine 
if Atg5flox/flox-LyzM-Cre+ mice develop osteosclerosis as they age.   
 We have identified a novel biochemical pathway involved in secretion in 
osteoclasts.  Autophagy genes have been implicated in secretion in other cell types, and 
the molecular mechanisms connecting autophagy genes and secretion are of great 
interest2,3,4,5,47.  In these studies it is unclear how the formation of autophagosomes would 
be necessary for secretion.  In osteoclasts, we favor the working hypothesis that LC3 is 
conjugated to the plasma membrane at the ruffled border, as suggested by our localization 
studies with GFP-LC3.  In our experiments employing the dominant negative protein 
ATG4BC74A, localization of GFP-LC3 correlates with osteoclast function, suggesting that 
LC3 localization might be important for vesicle secretion in osteoclasts (Fig. 4-16).  We 
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hypothesize that LC3 at the ruffled border is important for the trafficking or fusion of 
lysosomes with the plasma membrane.  Indeed, LC3 localization to the phagosome 
membrane correlates with increased fusion of phagosomes with lysosomes6.  How the 
resorptive microenvironment is targeted for LC3 localization remains to be determined. 
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Figure 4-1.  GFP-LC3 localizes to the actin ring in active osteoclasts 
Confocal image of a GFP-LC3 osteoclast grown on bone stained for actin (red), cathepsin 
K (ctsk, blue), and GFP (green) showing localization of cathepsin K and GFP-LC3 within 
the actin ring in both the xy plane and z plane.  Representative image from two separate 
experiments, 3 bones/experiment. 
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Figure 4-2.  Atg5flox/flox-LyzM-Cre+ cells have a slight delay in formation 
of TRAP+ multinucleated osteoclasts 
(A) Representative images of osteoclasts differentiated on plastic for 5 days from 
Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ macrophages, stained for the 
osteoclast marker TRAP (purple). (B) Quantification of the number of TRAP+ 
multinucleated cells in plastic cultures on day 3-5.  Quantification of one representative 
experiment from 5 independent experiments. P values generated by unpaired Student's t 
test, n.s. = not statistically significant.  
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Figure 4-3.  Atg5flox/flox-LyzM-Cre+ cells express osteoclast 
differentiation markers normally during osteoclastogenesis and form 
osteoclasts with normal numbers of nuclei 
(A) Immunoblot analysis of macrophages induced to differentiate into osteoclasts, probed 
against cathepsin K (Ctsk), c-Src, and β-actin.  Lysates were made on the indicated days 
after addition of osteoclastogenic cytokines.  One of four representative blots shown.  
(B) Quantification of the number of nuclei per osteoclast grown for 6 days on bone.  
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Individual cells were identified by actin staining and the number of nuclei counted per 
cell.  All cells with 3 or more nuclei were included in this analysis.  Data pooled from 
three independent experiments.  There was no statistically significant difference in mean 
nuclei number in any of the three experiments. 
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Figure 4-4.  Atg5flox/flox-LyzM-Cre+ osteoclasts express reduced levels of 
ATG5 and LC3-II and increased levels of p62 
Immunoblot analysis of lysates from Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ 
osteoclasts grown on plastic for 6 days.  Lysates were probed with antibodies against 
ATG5, p62, LC3, and β-actin.  Representative blot of 6 independent experiments. 
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Figure 4-5.  Atg5flox/flox-LyzM-Cre+ osteoclasts have a defect in bone pit 
formation 
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(A) Bone pits were imaged by removing osteoclasts grown on bone and staining 
degraded bone with FITC-conjugated wheat germ agglutinin.  Representative images of 
bone pits viewed in the z plane.  (B) Quantification of bone pit depth from one of four 
experiments, analyzed in a blinded fashion.  Each point represents an individual bone pit.  
P value generated by unpaired Student's t test.  (C) Pooled analysis of the mean bone pit 
depths from 4 independent, blindly read experiments.  To pool the results, we normalized 
the mean of the pit depth generated by Atg5flox/flox-LyzM-Cre+ cells to the mean depth 
generated by Atg5flox/flox-LyzM-Cre- cells, which was set to 100.  P value generated by 
paired Student's t test.   
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Figure 4-6.  Atg5flox/flox-LyzM-Cre+ osteoclasts have reduced localization 
of cathepsin K and LAMP1 in the actin ring 
(A) Representative confocal images of Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ 
osteoclasts, grown on bone and stained for actin (green) and cathepsin K (Ctsk, red).  (B) 
Quantification of the percentage of Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ 
osteoclasts with cathepsin K or LAMP1 localized in the actin ring.  Cells of each 
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genotype were grown on at least three pieces of bone in separate culture wells.  Each 
point represents the percentage of cells with localization from one bone – a minimum of 
10 cells analyzed per bone, with at least three bones analyzed per genotype per 
experiment.  All data was collected by a blinded observer.  The largest p value from any 
of the three experiments is shown, calculated by unpaired Student's t test. 
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Figure 4-7.  No difference in cathepsin K processing in Atg5flox/flox-LyzM-
Cre- and Atg5flox/flox-LyzM-Cre+ osteoclasts 
Immunoblot of lysates from Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ 
osteoclasts grown on plastic for 6 days and probed for cathepsin K (Ctsk) and β-actin.  
One representative of four independent experiments shown. 
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Figure 4-8.  Atg7flox/flox-LyzM-Cre+ osteoclasts have reduced expression 
of ATG7 and LC3-II 
Immunoblot analysis of lysates from day 6 Atg7flox/flox-LyzM-Cre- and Atg7flox/flox-LyzM-
Cre+ osteoclasts grown on plastic.  Lysates were probed for ATG7, LC3, and β-actin.  
One representative of three independent experiments shown. 
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Figure 4-9.  Atg7flox/flox-LyzM-Cre+ osteoclasts have a defect in bone pit 
formation and cathepsin K and LAMP1 localization 
(A) Quantification of bone pit depth from one of two experiments.  Each point represents 
an individual bone pit.  All data was collected by a blinded observer.  P value generated 
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by unpaired Student's t test.  (B) Quantification of the percentage of Atg7flox/flox-LyzM-
Cre- and Atg7flox/flox-LyzM-Cre+ osteoclasts with cathepsin K (Ctsk) or LAMP1 localized 
in the actin ring.  Each point represents the percentage of cells with localization from one 
bone – a minimum of 10 cells analyzed per bone, with at least two bones analyzed per 
genotype per experiment.  All data was collected by a blinded observer.  The largest p 
value from any of the two experiments is shown, generated by unpaired Student's t test. 
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Figure 4-10.  Expression of ATG5WT, but not ATG5K130R, rescues LC3 
conjugation in Atg5flox/flox-LyzM-Cre+ osteoclasts 
Immunoblot analysis of Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ osteoclasts 
transduced with control retrovirus or retroviruses expressing mCherry-Atg5WT or 
mCherry-ATG5K130R fusion proteins.  Lysates were probed for ATG5, LC3, and β-actin.  
Asterisks (*) indicate unpredicted bands that we hypothesize are degradation products of 
the fusion protein.  One of three experiments shown.   
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Figure 4-11.  Expression of ATG5WT, but not ATG5K130R, rescues bone 
pit depth and cathepsin K localization in Atg5flox/flox-LyzM-Cre+ 
osteoclasts 
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(A) Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ osteoclasts were transduced with 
control retroviruses or retroviruses expressing mCherry-ATG5WT or mCherry-
ATG5K130R.  Pooled analysis of the mean bone pit depths from 2-3 independent, blindly 
read experiments.  Data normalized as described in Figure 4-5.  P values calculated by 
paired Student's t test.  (B) Quantification of cathepsin K localization in actin rings in 
transduced Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ osteoclasts.  Average 
localization from 2-3 independent experiments was pooled.  All data was collected by a 
blinded observer.  P values generated by unpaired Student's t test. 
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Figure 4-12.  mStrawberry-ATG4BC74A is expressed in wild-type 
osteoclasts after retroviral transduction 
Immunoblot analysis of lysates from wild-type osteoclasts transduced with mStawberry-
ATG4BC74A-expressing or control retrovirus, probed with antibodies against ATG4B and 
β-actin.  The asterisk (*) indicates an unpredicted band that we hypothesize is a 
degradation product of the fusion protein.  One representative blot of three independent 
experiments shown. 
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Figure 4-13.  Transduction of wild-type osteoclasts with retrovirus 
expressing mStrawberry-ATG4BC74A causes a reduction in bone pit 
depth and cathepsin K localization 
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(A) Wild-type osteoclasts were transduced with control retrovirus or retrovirus 
expressing mStrawberry-ATG4BC74A.  Pooled analysis of the mean bone pit depths from 
3 independent, blindly read experiments.  Data normalized as described above in Figure 
4-5.  P values generated by paired Student's t test.  (B) Quantification of the percentage of 
mStrawberry-ATG4BC74A or control transduced osteoclasts with cathepsin K (Ctsk) 
localized in the actin ring.  Each point represents the percentage of cells with localization 
from one bone – a minimum of 10 cells analyzed per bone, with at least three bones 
analyzed per genotype per experiment.  All data was collected by a blinded observer.  
The largest p value from any of the three experiments is shown, generated by unpaired 
Student's t test. 
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Figure 4-14.  Expression of mStrawberry-ATG4BC74A in GFP-LC3 
osteoclasts decreases GFP-LC3 localization in the actin ring 
Quantification of the percentage of mStrawberry-ATG4BC74A or control transduced 
osteoclasts with GFP-LC3 localized in the actin ring.  Each point represents the 
percentage of cells with localization from one bone – a minimum of 10 cells analyzed per 
bone, with at least three bones analyzed per genotype per experiment.  All data was 
collected by a blinded observer.  The largest p value from either experiment is shown, 
generated by unpaired Student's t test. 
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Figure 4-15.  Atg5flox/flox-LyzM-Cre+ mice are protected from 
ovariectomy-induced bone loss 
(A) Trabecular bone volume over total volume of the marrow space (BV/TV) of 8-week 
old female Atg5flox/flox-LyzM-Cre- and Atg5flox/flox-LyzM-Cre+ mice, as measured by 
microcomputed tomography.  Pooled data from 3 independent experiments, n = 12 mice 
per genotype.  P value generated by unpaired Student's t test. (B)  Quantification of 
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ovariectomy-induced bone loss.  BV/TV was measured at day 0, mice were 
ovariectomized or sham operated on day 1, and BV/TV was reanalyzed at day 29.  The 
average bone loss in sham-operated Atg5flox/flox-LyzM-Cre- control animals was 
subtracted from all measurements.  Pooled data from 2 (sham) or 3 (ovariectomy) 
independent experiments, n = 4-5 mice for the sham treatment and 7-8 mice for the 
ovariectomy treatment groups. 
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Figure 4-16.  Working hypothesis for the role of LC3 and the LC3 
conjugation pathway in osteoclast function 
We propose the following model to explain the function of the LC3 conjugation pathway 
in osteoclast secretion.  (1) We speculate that the LC3 conjugation cascade (see Fig. 1-1), 
employing ATG7, the ATG5-ATG12 conjugate, and ATG4B, is involved in localization 
of LC3 to the ruffled border, suggesting that LC3 is directly conjugated to the ruffled 
border (2).  We did not observe colocalization of LC3 and cathepsin K puncta in the cell 
periphery, arguing that LC3 is not conjugated to the membranes of secretory lysosomes.  
At the ruffled border, LC3 may function either to promote (green arrows) trafficking of 
cathepsin K-containing, LAMP1 positive vesicles to the ruffled border (3) or the fusion 
of these vesicles with the plasma membrane (4).  Key: cathepsin K (Ctsk) – blue; LAMP1 
– red; conjugated LC3 – green box with green line; bone – orange box 
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Materials and Methods 
Mice  The generation of Atg5flox/flox, Atg7flox/flox, Atg5flox/flox-LyzM-Cre+, and GFP-LC3 
mice has been previously reported17,31,18,13.  To generate Atg7flox/flox-LyzM-Cre+ mice, we 
bred mice Atg7flox/flox mice to mice expressing the Cre recombinase from the Lysozyme M 
locus (strain #004781, Jackson Laboratory, Bar Harbor, ME).  Atg5flox/flox, Atg7flox/flox, 
Atg5flox/flox-LyzM-Cre+ mice were genotyped as described48.  GFP-LC3 mice were 
genotyped with primers GFP-1: 5′-TCCTGCTGGAGTTCGTGACCG-3′ and LC3: 5′-
TTGCGAATTCTCAGCCGTCTTCA 
TCTCTCTCGC-3′ using PCR [94°C(4 min); 35 cycles of 94°C (30 sec), 57°C (30 sec), 
72°C (1 min); 72°C (5 min)].   Mice were maintained at Washington University School 
of Medicine in accordance with institutional policies for animal care and usage. 
 
Cell culture  Osteoclasts were grown in alpha10 media, containing alpha-MEM 
(Sigma Aldrich, St. Louis, MO), 10% fetal calf serum (Hyclone, Waltham, MA), 
100U/mL penicillin and 100ug/mL streptomycin.  Plat-E retrovirus packaging cells were 
purchased from Cell Biolabs, Inc. (San Diego, CA) and maintained in DMEM media 
(Cellgro, Manassas, VA) containing 10% fetal calf serum (Hyclone, Waltham, MA), and 
2mM L-glutamine (Gibco, Carlsbad, CA).  Osteoclasts were differentiated from bone 
marrow as described, with minor modifications42.  Briefly, bone marrow was extracted 
from mice and cultured in the presence of 10% CMG 14-12 supernatant49, an M-CSF-
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containing cell supernatant, on day -4.  After 4 days (day 0), cells were lifted and replated 
on plastic or bovine bone fragments in alpha10 media supplemented with 2% CMG and 
100ng/mL recombinant RANKL.  Bone grown cells were fixed in 4% paraformaldehyde 
6 or 7 days after plating for immunofluorescence and bone pit measurements.  Plastic-
grown cells were fixed on days 3, 4, and 5 in 4% paraformaldehyde/PBS for 
osteoclastogenesis or lysed on various days for immunoblot analysis.  TRAP staining on 
fixed cells was performed using a commercially available kit according to the 
manufacturer's instructions (Sigma, St. Louis, MO). 
 
Retroviral DNA constructs  mCherry-ATG5WT and mCherry-ATG5K130R were 
generated in the laboratory of Dr. A. B. Gustafsson33.  mStrawberry-ATG4BC74A was 
kindly provided by Dr. T. Yoshimori37.  The eGFP construct was purchased from 
Clontech (Mountain View, CA).  All constructs were cloned into the pMXs-IRES-Puro 
retroviral vector (Cell Biolabs, Inc., San Diego, CA).  eGFP-IRES-Puro retrovirus and 
vector only retrovirus were used as controls. 
 
Retroviral transduction  Retroviral transduction of bone marrow macrophages was 
done as previously described, with slight modifications42.  Briefly, 8ug of retroviral DNA 
was transfected into Plat-E cells using the Fugene HD transfection reagent (Roche, Basel, 
Switzerland) the same day as bone marrow isolation.  Plat-E media was replaced 24 
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hours later and virus harvested 48 and 72 hours after for transduction of plated bone 
marrow cells.  To transduce the bone marrow cells, culture media was replaced at 48 and 
72 hours with alpha10 containing 25% Plat-E viral media, 10% CMG 14-12 supernatant, 
and 4ug/mL polybrene.  At 96 hours the transduction media was replaced with alpha10 
with 10% CMG 14-12 supernatant and 2ug/mL puromycin.  Cells were allowed to grow 
for 3 days before being harvested and plated to form osteoclasts.  Control, untransduced 
cells were killed by the puromycin. 
 
Immunofluorescence  Osteoclasts grown on bone fragments were fixed in 4% 
paraformaldehyde for 10 minutes and washed in PBS.  Cells were permeabilized in 0.1% 
Triton-X for 10 minutes at room temperature and blocked for 1 hour in PBS containing 
0.2% BSA, 10% normal goat serum, and 10% normal rabbit serum.  The following 
antibodies and detection reagents were used: anti-cathepsin K (Millipore, Billerica, MA) 
(1:500 dilution), mouse IgG1 isotype control (Southern Biotech, Birmingham, AL), anti-
GFP conjugated to Alexa 488 (Molecular Probes, Carlsbad, CA), polyclonal rabbit 
antibody conjugated to Alexa 488 isotype control (anti-fluorescein, Molecular Probes, 
Carlsbad, CA),  anti-CD107a (eBioscience, San Diego, CA), rat anti-mouse IgG2a 
isotype control (anti-mouse CD8a, BD Biosciences, San Jose, CA), phalloidin-Alexa 555 
and phalloidin-Alexa 488 (Molecular Probes, Carlsbad, CA), goat anti-rat-Alexa 488 
(Molecular Probes, Carlsbad, CA), goat anti-mouse Cy5 (Jackson Immunoresearch, West 
Grove, PA), and donkey anti-mouse-Alexa 555 (Jackson Immunoresearch, West Grove, 
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PA).  All antibodies were diluted in blocking buffer.  Primary antibodies were applied 
overnight.  After washing in PBS, secondary antibodies were applied for 1 hour at room 
temperature.  Bones were then mounted in 30% glycerol or VECTASHIELD Mounting 
Media with DAPI (Vector labs, Burlingame, CA) and imaged on a Nikon Eclipse 
epifluorescent microscope (Nikon, Melville, NY), Olympus BX51 epifluorescent 
microscope (Olympus, Center Valley, PA), or Axiovert 100M confocal microscope 
(Zeiss, Thornwood, NY).  Confocal images were analyzed using LSM 510 software 
(Zeiss, Thornwood, NY).  For localization of GFP-LC3, cathepsin K, and LAMP1, 
confocal microscopy was used to identify cells with complete actin rings.  If the area 
outlined by the actin ring was completely occupied by CatK in any z-plane containing the 
actin ring, and CatK was not visualized outside the ring in those z-planes, the cell was 
said to have positive CatK localization.  The same procedure was followed for LAMP1 
and GFP-LC3 localization.  All data was collected by a blinded observer. 
 
Bone pit depth measurements  Osteoclast-generated bone pits were stained by 
removing the cells from bone fragments with a soft brush and incubating with 20ug/mL 
FITC conjugated wheat germ agglutinin (Sigma, St. Louis, MO) for 30 minutes at room 
temperature.  After washing the bones, pits were imaged by confocal microscopy.  The 
pit depth was measured from the surface of the bone down to the deepest point in the pit.  
All data was collected by a blinded observer. 
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Nuclei and actin ring measurements  Osteoclasts were grown on bone for 6 days 
and fixed and permeabilized as described above.  Cells were stained with Alexa 555-
conjugated phalloidin and mounted with VECTASHIELD Mounting Media with DAPI to 
visualize actin rings and nuclei.  Actin rings were quantified in any cell with at least three 
nuclei.  Nuclei per cell were quantified counting any cell with at least three nuclei. 
 
Immunoblots  Cells were lysed in RIPA buffer + protease inhibitors for 10 minutes on 
ice, the lysates were clarified, 5x Laemmli sample buffer added, and the samples boiled.  
Immunoblotting was performed using antibodies against ATG5 (Nanotools, Teningen 
Germany) (1:200 dilution), LC3 (Cosmo Bio Co, LTD, Tokyo, Japan) (1:500 dilution), 
ATG7 (Sigma-Aldrich, St. Louis MO) (1:2,000 dilution), B-actin (Sigma-Aldrich, St. 
Louis MO) (1:40,000 dilution), p62 (Progen Biotechnik, Heidelberg, Germany) (1:1,000 
dilution), ATG4B (MBL, Woburn, MA) (1:1,000 dilution), c-Src (monoclonal antibody 
directed against c-Src was a gift from A. Shaw) (final concentration: 2ug/mL), and 
cathepsin K (Millipore, Billerica, MA) (1:500 dilution). 
 
Microcomputed tomography and ovariectomy  Trabecular volume in the distal 
femoral metaphysis (right leg) was measured using in vivo microcomputed tomography 
(vivaCT 40, Scanco Medical, Brüttisellen, Switzerland) while the mice were anesthetized 
with isofluorane.  A threshold linear attenuation coefficient of 1.2 cm− 1 was used to 
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differentiate bone from non-bone.  A threshold of 120 was used for evaluation of all 
scans. 30 slices were analyzed, starting with the first slice in which condyles and primary 
spongiosa were no longer visible.  Trabecular volume was measured one day before 
ovariectomy or sham operation (basal bone volume) and 28 days after surgery (post-ovx).  
For ovariectomies, mice were anesthetized with ketamine/xylene delivered by 
intraperitoneal injection, and ovaries were removed through two small dorsal incisions.  
Sham operated mice were anesthetized and opened equivalently, but ovaries were not 
removed. 
 
Statistics  All data was analyzed with Prism software (Graphpad, San Diego, CA), 
using two-tailed unpaired or paired Student’s t tests, as indicated.  Error bars represent 
standard error of the mean (SEM). 
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CHAPTER 5 
Conclusions and Future Directions 
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Summary of Results 
 The canonical functions of autophagy are to degrade unwanted cytoplasmic 
constituents and provide recycled material back to the cell.  As groups have identified 
and studied the molecular mechanisms of autophagy in a variety of model organisms and 
cell types, it has become clear that autophagy and autophagy genes have a plethora of 
additional functions.  The goal of this thesis is to better understand the functions of 
autophagy genes in primary mammalian cells with important physiologic functions.  We 
chose to study B cells, T cells, and osteoclasts because much is known about the 
development, homeostasis, and functions of these cell types.   
 Our studies in lymphocytes revealed a role for autophagy genes in cellular 
development and homeostasis.  B cells lacking Atg5 had an increase in cell death during 
the late stages of development in the bone marrow and decreased numbers of B-1a B 
cells.  In contrast, T cells deficient in either Atg5 or Atg7 had a profound defect in 
peripheral homeostasis, associated with an increase in markers of cell death and 
decreased ability to proliferate.  Transcriptional studies suggested abnormalities in 
mitochondria, which we corroborated by demonstrating an increase in mitochondrial 
mass.  High mitochondrial mass correlated with the increased markers of cell death in 
Atg5-deficient T cells. 
 In contrast to lymphocytes, Atg5-deficient osteoclasts did not have gross 
abnormalities in cellular development.  Instead, these cells had a reduction in their 
capacity to degrade bone.  Delivery of the lysosomal markers cathepsin K and LAMP1 to 
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the bone surface was impaired in the absence of Atg5, suggesting a role for Atg5 in cell 
secretion.  To further explore the mechanism behind this observation, we showed that 
osteoclasts lacking Atg5 or Atg7 or overexpressing ATG5K130R or ATG4BC74A all shared 
the same phenotype.  Together, this data identifies the biochemical pathway necessary for 
LC3 conjugation as important for osteoclast secretion.  Interestingly, LC3 is found at the 
ruffled border in activated osteoclasts.  This localization is inhibited by ATG4BC74A 
expression, suggesting a connection between LC3 localization and osteoclast function. 
 
Conclusions and Future Directions: Lymphocytes 
Cell type specificity 
 Our studies reveal that Atg5 has very dramatic cell-type specific functions.  B and 
T lymphocytes are closely-related lineages that differentiate from a common progenitor, 
yet Atg5 is required for peripheral T cell, but not B-2 B cell, homeostasis.  Also, T cells 
accumulate mitochondria in the absence of Atg5, whereas peripheral B-2 B cells do not1.  
Even more striking is the discrepancy within B cells – B-1a B cell numbers are 
dramatically reduced in Atg5flox/flox-CD19-Cre+ mice, but B-1b and B-2 B cells are not.  
These results demonstrate that one must be cautious when taking lessons learned about 
the function of autophagy genes in one biological system or cell type and trying to apply 
them to another, and support our bias that it is necessary to study the function of 
autophagy genes in primary cells with physiologically important roles. 
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Autophagy in lymphocyte survival and death 
 There are many reports in the literature that autophagy can accelerate or induce 
cell death in different cell types2,3,4.  Even within the T cell literature, autophagy is 
suggested to be an important death pathway after nutrient withdrawal, exposure to HIV, 
or in a variety of genetic deletion models5,6,7,8.  In contrast to these results, we observed 
either no effect or an increase in cell death when we deleted autophagy genes in primary 
T cells.  If autophagy were a physiologically important cell death pathway in 
lymphocytes, one would have predicted an accumulation of B and T cells, possibly 
resulting in autoimmunity.  We have followed both Atg5flox/flox-CD19-Cre+ and 
Atg5flox/flox-Lck-Cre+ mice and their Cre- controls as they age and have not seen 
abnormalities in long-term survival.  We hypothesize that in physiologic circumstances 
autophagy functions as a pro-survival mechanism in lymphocytes, and that this process is 
only important for inducing cell death in conditions of genetic abnormalities or when 
excessively induced. 
 One of the major questions raised by our studies in T lymphocytes is why the lack 
of Atg5 or Atg7 resulted in decreased T cell survival.  Both our work and the work of Pua 
et al.1 demonstrate that mitochondria are abnormal in the absence of essential autophagy 
genes, suggesting that autophagy is important in T cells for degradation of excess or 
damaged mitochondria.  While it is known that damaged mitochondria can produce toxic 
byproducts, such as reactive oxygen species, that can result in cell death, we were unable 
to rescue T cell survival with pharmacologic inhibitors of reactive oxygen species (data 
not shown).  Until Atg5-deficient T cells can be rescued from cell death, the downstream 
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cause of death from deletion of essential autophagy genes will be unknown.  Given the 
important role of Bcl-2 family members in T cell survival and the misregulation of these 
proteins in Atg7-deficient T cells1, one hypothesis is that disruption in the balance of pro- 
and anti-apoptotic Bcl-2 family members contributes to T cell death in the absence of 
autophagy genes.  One could breed Atg5flox/flox-Lck-Cre mice to mice expressing Bcl-2 in 
T cells9 to determine if overexpression of this anti-apoptotic molecule protects Atg5-
deficient T cells from death and restores peripheral T cell numbers.  Rescue of Atg5-
deficient T cell death by Bcl-2 overexpression would suggest that the T cells are dying in 
a Bax/Bad-dependent fashion, prompting further studies of the regulation of these family 
members in Atg5-deficient T cells. 
 
B cell secretion 
 Given the role of autophagy genes in osteoclast secretion, it would be interesting 
to determine if B lymphocytes lacking Atg5 are able to secrete antibody.  Atg5flox/flox-
CD19-Cre mice provide a good model system in which to study B cell antibody 
production, both in vivo and in vitro.  Antibody titers in serum from naïve Atg5flox/flox-
CD19-Cre+ mice should be measured to determine if Atg5 is important for the 
homeostasis of antibody levels.  Given that antibody levels are tightly regulated,10 a 
deficiency in B cell secretion may not be observable until the mice are challenged to 
produce an antibody response.  Injection of mice with standard, well-characterized 
antigens that elicit robust immunoglobulin production (i.e. TNP-KLH) would allow 
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measurement of specific antibody responses.  Also, B cell antibody production can be 
measured in vitro by stimulating cells with LPS and measuring total IgM levels in the 
supernatant.  Given that our anti-phosphocholine titer experiments in these mice suggest 
that Atg5-deficient B cells are able to secrete antibody, we hypothesize that antibody 
secretion will be unaffected in Atg5flox/flox-CD19-Cre+ B cells.  It is likely that autophagy 
genes are not involved in secretion in every cell type, as mice lacking Atg5 or Atg7 in 
neurons are able to survive for weeks, proving that neuronal secretion is not dramatically 
inhibited11,12. 
 
Conclusions and Future Directions: Osteoclasts 
 The function of autophagy genes in cell secretion is an area of active interest in 
our lab, given the importance of these genes in Paneth cell secretion and the work 
described in Chapter 4 in osteoclasts.  Osteoclasts provide a manipulable in vitro system 
for pursuing mechanistic questions.  Using this system we have identified that the LC3 
conjugation pathway is important for osteoclast secretion, and our data suggest that LC3 
localization to the ruffled border may be involved.  Based on this data we have developed 
a working model summarized in Figure 4-16. 
Exploring the role of LC3 in osteoclasts 
 To test our working model, one must first confirm that LC3 localization to the 
ruffled border requires LC3 conjugation.  Second, identification of the membrane(s) onto 
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which LC3 is conjugated would guide our hypotheses about the function of LC3.  Finally, 
direct assessment of LC3 function would be important to determine the mechanism of its 
action at the ruffled border.  Each of these three lines of inquiry is discussed in more 
detail below. 
 The first hypothesis predicted from our model is that LC3 conjugation is required 
for localization of GFP-LC3 to the ruffled border.  Our studies with the ATG4BC74A 
mutant suggest this conclusion, but given that this mutant binds to and sequesters LC313, 
it is possible that the inhibition in GFP-LC3 localization is simply due to sequestering of 
LC3 in the cytoplasm.  To test if conjugation is required for localization, one could 
transduce GFP-LC3 into cells lacking ATG5.  We predict that GFP-LC3 will localize to 
the ruffled border in Atg5flox/flox-LyzM-Cre- but not Atg5flox/flox-LyzM-Cre+ osteoclasts, 
indicating that Atg5 is required for LC3 localization.  This hypothesis could be further 
assessed by transducing control osteoclasts with a mutant of LC3 that cannot be 
conjugated to phosphatidylethanolamine (LC3G120A)14.  If our hypothesis is correct, then 
GFP-LC3WT, but not GFP-LC3G120A, will localize to the ruffled border.  If LC3 
conjugation is not required for localization, then one would study the functions of the 
LC3 conjugation pathway outside of the context of LC3.  For example, this pathway is 
required for conjugation of additional mammalian ATG8 homologues, including 
GABARAP, GATE16, and ATG8L15,16,17, that may be responsible for the observed 
osteoclast phenotype. 
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 If LC3 conjugation is required for its localization, it will be important to know 
what structure(s) LC3 is conjugated to within the actin ring.  Immunoelectron microscopy 
of active GFP-LC3 osteoclasts on bone should allow us to determine if the LC3 is located 
on the plasma membrane or on vesicles or autophagosomes near the ruffled border.  
Electron microscopy would also be useful to determine if there are any double-membrane 
bound vesicles in the vicinity of the ruffled border in control cells which might suggest a 
role for autophagosomes in cell secretion.   
 Finally, the function of LC3 in mediating directional secretion needs to be 
determined.  As a first step towards addressing this question, it would be useful to 
understand the kinetics of LC3 localization using live cell imaging of osteoclasts on bone 
substrate18.  Luckily, live imaging of both the dynamics of actin ring formation in 
osteoclasts and GFP-LC3 localization in macrophages has already been reported,19,18 
suggesting that it might be possible to visualize both of these processes in live 
osteoclasts.  Trafficking of lysosomes can also be visualized in live cells20. 
 Kinetic analysis experiments might explain two puzzling observations from our 
studies: first, why we observe GFP-LC3 localization in only 25% of osteoclasts, despite 
localization of cathepsin K in 50% of osteoclasts; second, why nearly 100% of cells with 
localization of GFP-LC3 in the actin ring also had localization of cathepsin K in the actin 
ring.  Three non-mutually exclusive hypotheses may explain these results.  First, LC3 
localization may function to enhance secretion (through some of potential mechanisms 
discussed below), but may not required for initial secretion.  Visualizing the kinetics of 
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lysosome and GFP-LC3 trafficking to the actin ring could address this hypothesis.  
Second, targeting of LC3 to the ruffled border may be a transient signal that rapidly 
initiates secretion.  Kinetic studies would also address this hypothesis.  Third, cathepsin 
K and LAMP1 may be targeted to the ruffled border via two distinct secretory pathways 
(i.e. secretory lysosomes and directly from the Golgi apparatus, see Chapter 1), only one 
of which requires the LC3 conjugation machinery.  To study this hypothesis, one would 
need to do a detailed analysis of cathepsin K secretion in osteoclasts.  Luckily, such an 
analysis is currently underway in the laboratory of one of our collaborators, Dr. Judith 
Klumperman.  Understanding which, if any, of these hypotheses is correct may also 
explain why Atg5- and Atg7-deficient osteoclasts still are able to form shallow bone pits 
and localize cathepsin K in a fraction of cells. 
  LC3 is a multifunctional protein that could mediate directional secretion in 
osteoclasts through several potential mechanisms.  First, LC3 interacts with many 
different proteins in the cell21,22,23,24 including p62, an important molecule in osteoclast 
biology.  Second, LC3 promotes the tethering and hemifusion of membranes25, 
suggesting it may be part of the machinery necessary for vesicle fusion with the plasma 
membrane at the ruffled border.  Third, LC3 binds to microtubules26, suggesting that it 
might be important for vesicle trafficking on the cytoskeleton.  As we do not observe 
colocalization of GFP-LC3 and cathepsin K puncta in the cell periphery in osteoclasts, 
we do not believe that LC3 is localized to secretory lysosomes in osteoclasts and will not 
discuss this hypothesis further. 
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 P62 is an attractive target for study because mutations in p62 have been 
associated with Paget's disease of bone (PDB), a human disease characterized by focal 
areas of bone degradation and hyperactive osteoclasts (reviewed in 27).  Understanding 
the role of p62 in PDB has been very complicated because of the multiple roles of this 
scaffolding protein, including interacting with many signaling molecules necessary for 
osteoclast formation28.  There is little known about the functions of p62 in osteoclasts 
outside of these osteoclastogenic signaling pathways.  LC3 targeted to the ruffled border 
may function by binding p62, localizing this important scaffold molecule to the 
resorptive microenvironment.  As a first step to understand if LC3 binding to p62 is 
potentially important for the function of LC3 at the ruffled border, one could determine if 
p62 localizes within the actin ring and colocalizes with LC3.  It would also be useful to 
determine if the interaction of these proteins is important by studying mutants of p62 that 
abolish LC3 binding29,23.  Transducing these mutants into p62-/- macrophages before 
inducing osteoclastogenesis may rescue the defect in osteoclast formation in these cells28 
and allow analysis of the function of the p62-LC3 interaction in osteoclasts. 
 LC3 is also involved in membrane tethering and hemifusion, an important 
function for autophagosome formation25.  The fusion machinery required for secretion of 
vesicles at the ruffled border in osteoclasts is unknown.  The ability of LC3 to facilitate 
membrane tethering and fusion may be important at the ruffled border for either bringing 
the vesicular membrane in proximity with the plasma membrane or for directly fusing 
these two membranes to allow release of vesicular contents.  To test this hypothesis, one 
could generate mutants of LC3 that cannot participate in membrane fusion.  These 
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mutants have already been generated and characterized in ATG8, the yeast homologue of 
LC325.  Overexpression of these mutants in osteoclasts may inhibit secretion.   
Differentiating the functions of autophagy from the functions of 
autophagy genes 
 As discussed briefly throughout this thesis, one of the major challenges that the 
field of autophagy is now facing is to understand the difference between the functions of 
autophagy genes and the autophagy pathway.  The gold standard for defining that a 
phenotype is dependent on autophagy requires demonstration that the mechanism 
involves a function of autophagosomes, such as degradation of long-lived proteins or 
organelles.  Alternatively, inhibiting the autophagy pathway at multiple points, from 
induction to autophagosome-lysosome fusion, and demonstrating that each has the same 
phenotype is highly suggestive that autophagosome formation is involved.  
Unfortunately, even processes that require proteins from multiple steps in autophagosome 
formation may not involve classical autophagy.  For example, both Beclin-1 and LC3 
localize to single-membrane bound phagosomes before phagosome-lysosome fusion19, 
suggesting co-opting of the autophagy machinery from the class III PI3K to LC3 
conjugation for phagosome maturation.   
 Our studies in osteoclasts have identified that the LC3 conjugation pathway is 
important for secretion, but we do not know if this pathway is working in the context of 
autophagosome formation or in an alternative role.  To address this question, one could 
knock down or knock out proteins in the autophagy pathway outside of the LC3 
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conjugation pathway and determine if osteoclast secretion is inhibited.  Since many of the 
upstream signaling molecules have separate functions in vesicular trafficking30,31 
(reviewed in 32), targets for knockdown must be carefully selected.  mATG9 is a 
homologue of the yeast protein ATG9 that is hypothesized to transport membrane to the 
forming autophagosome (reviewed in 33).  ATG14L is a binding partner in the Vps34-
beclin complex necessary for autophagosome induction30,31.  Knocking down these 
proteins in mammalian cells inhibits autophagosome formation34,30,31 but is not known to 
affect vesicular trafficking.  If knocking down expression of these proteins does not affect 
osteoclast secretion but still inhibits autophagosome formation in osteoclasts, this would 
demonstrate that autophagosomes are not required for osteoclast secretion.  ATG14L, and 
possibly mATG9, is important for LC3 conjugation34,30,31.  If these knockdowns do 
inhibit osteoclast secretion but also inhibit LC3 conjugation, it does not prove that 
autophagosomes are required for secretion.  The best approach is to inhibit multiple 
proteins both upstream and downstream of LC3 conjugation and demonstrate that they all 
result in defects in osteoclast secretion.  This result would be highly suggestive that 
formation of autophagosomes is important for osteoclast secretion.  The alternative 
hypothesis is that the biochemical pathway required for autophagy has an entirely 
separate and currently undefined function in secretion.  Immunoelectron microscopy 
studies to localize LC3 and electron microscopy to visualize double-membrane bound 
vesicles in osteoclasts would help distinguish between these two hypotheses. 
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Autophagy genes in cell secretion 
 Cell secretion in osteoclasts is not well understood, but a number of lines of 
evidence suggest that the vesicles involved in secretion are secretory lysosomes (see 
Chapter 1).   It is interesting to note that of the three cell types in which autophagy genes 
have been shown to be important for secretion – Paneth cells, melanocytes, and now 
osteoclasts – both melanocytes and osteoclasts utilize secretory lysosomes (reviewed in 
35).  This suggests that there may be a common mechanism employing autophagy 
machinery for the secretion of lysosomes.  Also, this may explain why some cells require 
autophagy genes for secretion, whereas other cells do not.  It would be interesting to 
determine if the role of autophagy genes in cell secretion is specific for secretory 
lysosomes, and if this role is applicable across multiple cell types. 
 Related to the hypothesis that there may be a common mechanism for the 
secretion of lysosomes that involves the autophagy machinery, a small GTPase, Rab7, is 
known to be important both for autophagosome fusion to lysosomes36,20,37  and osteoclast 
localization of vacuolar H+ ATPase to the actin ring38.  These results suggest that 
molecular machinery may be shared between autophagosome maturation and vesicular 
secretion in osteoclasts.  This may be due to a role for autophagosomes in secretion or a 
function of the LC3 conjugation pathway in recruiting shared mechanisms.  It would be 
interesting to determine if additional molecules involved in autophagosome maturation, 
such as the vesicular snare VAMP739, are also involved in vesicular secretion in 
osteoclasts and other cell types with secretory lysosomes. 
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 In conclusion, we have shown that autophagy genes have important functions in 
survival, development, mitochondrial maintenance, and secretion in primary mammalian 
cells.  We have also demonstrated that these functions are highly cell-type specific.  
Together, these results suggest that autophagy or autophagy genes have been co-opted for 
multiple functions during evolution. 
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